Human metabolic models and methods

BACKGROUND OF THE INVENTION

[0002] This invention relates generally to analysis of the activity of chemical reaction networks and, more specifically, to computational methods for simulating and predicting the activity of Homo sapiens reaction networks.

[0003] Therapeutic agents, including drugs and gene-based agents, are being rapidly developed by the pharmaceutical industry with the goal of preventing or treating human disease. Dietary supplements, including herbal products, vitamins and amino acids, are also being developed and marketed by the nutraceutical industry. Because of the complexity of the biochemical reaction networks in and between human cells, even relatively minor perturbations caused by a therapeutic agent or a dietary component in the abundance or activity of a particular target, such as a metabolite, gene or protein, can affect hundreds of biochemical reactions. These perturbations can lead to desirable therapeutic effects, such as cell stasis or cell death in the case of cancer cells or other pathologically hyperproliferative cells. However, these perturbations can also lead to undesirable side effects, such as production of toxic byproducts, if the systemic effects of the perturbations are not taken into account.

[0004] Current approaches to drug and nutraceutical development do not take into account the effect of a perturbation in a molecular target on systemic cellular behavior. In order to design effective methods of repairing, engineering or disabling cellular activities, it is essential to understand human cellular behavior from an integrated perspective.

[0005] Cellular metabolism, which is an example of a process involving a highly integrated network of biochemical reactions, is fundamental to all normal cellular or physiological processes, including homeostatis, proliferation, differentiation, programmed cell death (apoptosis) and motility. Alterations in cellular metabolism characterize a vast number of human diseases. For example, tissue injury is often characterized by increased catabolism of glucose, fatty acids and amino acids, which, if persistent, can lead to organ dysfunction. Conditions of low oxygen supply (hypoxia) and nutrient supply, such as occur in solid tumors, result in a myriad of adaptive metabolic changes including activation of glycolysis and neovascularization. Metabolic dysfunctions also contribute to neurodegenerative diseases, cardiovascular disease, neuromuscular diseases, obesity and diabetes. Currently, despite the importance of cellular metabolism to normal and pathological processes, a detailed systemic understanding of cellular metabolism in human cells is currently lacking.

[0006] Thus, there exists a need for models that describe Homo sapiens reaction networks, including core metabolic reaction networks and metabolic reaction networks in specialized cell types, which can be used to simulate different aspects of human cellular behavior under physiological, pathological and therapeutic conditions. The present invention satisfies this need, and provides related advantages as well.

SUMMARY OF THE INVENTION

[0007] The invention provides a computer readable medium or media, including: (a) a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product, (b) a constraint set for the plurality of Homo sapiens reactions, and (c) commands for determining at least one flux distribution that minimizes or maximizes an objective function when the constraint set is applied to the data representation, wherein the at least one flux distribution is predictive of a Homo sapiens physiological function. In one embodiment, at least one of the Homo sapiens reactions in the data structure is annotated to indicate an associated gene and the computer readable medium or media further includes a gene database including information characterizing the associated gene. In another embodiment, at least one of the Homo sapiens reactions is a regulated reaction and the computer readable medium or media further includes a constraint set for the plurality of Homo sapiens reactions, wherein the constraint set includes a variable constraint for the regulated reaction.

[0008] The invention provides a method for predicting a Homo sapiens physiological function, including: (a) providing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product; (b) providing a constraint set for the plurality of Homo sapiens reactions; (c) providing an objective function, and (d) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, thereby predicting a Homo sapiens physiological function. In one embodiment, at least one of the Homo sapiens reactions in the data structure is annotated to indicate an associated gene and the method predicts a Homo sapiens physiological function related to the gene.

[0009] The invention provides a method for predicting a Homo sapiens physiological function, including: (a) providing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product, wherein at least one of the Homo sapiens reactions is a regulated reaction; (b) providing a constraint set for the plurality of Homo sapiens reactions, wherein the constraint set includes a variable constraint for the regulated reaction; (c) providing a condition-dependent value to the variable constraint; (d) providing an objective function, and (e) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, thereby predicting a Homo sapiens physiological function.

[0010] Also provided by the invention is a method for making a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions in a computer readable medium or media, including: (a) identifying a plurality of Homo sapiens reactions and a plurality of Homo sapiens reactants that are substrates and products of the Homo sapiens reactions; (b) relating the plurality of Homo sapiens reactants to the plurality of Homo sapiens reactions in a data structure, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product; (c) determining a constraint set for the plurality of Homo sapiens reactions; (d) providing an objective function; (e) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, and (f) if the at least one flux distribution is not predictive of a Homo sapiens physiological function, then adding a reaction to or deleting a reaction from the data structure and repeating step (e), if the at least one flux distribution is predictive of a Homo sapiens physiological function, then storing the data structure in a computer readable medium or media. The invention further provides a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein the data structure is produced by the method.

BRIEF DESCRIPTION OF THE DRAWINGS

[0011]
FIG. 1 shows a schematic representation of a hypothetical metabolic network.

[0012]
FIG. 2 shows mass balance constraints and flux constraints (reversibility constraints) that can be placed on the hypothetical metabolic network shown in FIG. 1.

[0013]
FIG. 3 shows the stoichiometric matrix (S) for the hypothetical metabolic network shown in FIG. 1.

[0014]
FIG. 4 shows, in Panel A, an exemplary biochemical reaction network and in Panel B, an exemplary regulatory control structure for the reaction network in panel A.

DETAILED DESCRIPTION OF THE INVENTION

[0015] The present invention provides in silico models that describe the interconnections between genes in the Homo sapiens genome and their associated reactions and reactants. The models can be used to simulate different aspects of the cellular behavior of human cells under different normal, pathological and therapeutic conditions, thereby providing valuable information for therapeutic, diagnostic and research applications. An advantage of the models of the invention is that they provide a holistic approach to simulating and predicting the activity of Homo sapiens cells. The models and methods can also be extended to simulate the activity of multiple interacting cells, including organs, physiological systems and whole body metabolism.

[0016] As an example, the Homo sapiens metabolic models of the invention can be used to determine the effects of changes from aerobic to anaerobic conditions, such as occurs in skeletal muscles during exercise or in tumors, or to determine the effect of various dietary changes. The Homo sapiens metabolic models can also be used to determine the consequences of genetic defects, such as deficiencies in metabolic enzymes such as phosphofructokinase, phosphoglycerate kinase, phosphoglycerate mutase, lactate dehydrogenase and adenosine deaminase.

[0017] The Homo sapiens metabolic models can also be used to choose appropriate targets for drug design. Such targets include genes, proteins or reactants, which when modulated positively or negatively in a simulation produce a desired therapeutic result. The models and methods of the invention can also be used to predict the effects of a therapeutic agent or dietary supplement on a cellular function of interest. Likewise, the models and methods can be used to predict both desirable and undesirable side effects of the therapeutic agent on an interrelated cellular function in the target cell, as well as the desirable and undesirable effects that may occur in other cell types. Thus, the models and methods of the invention can make the drug development process more rapid and cost effective than is currently possible.

[0018] The Homo sapiens metabolic models can also be used to predict or validate the assignment of particular biochemical reactions to the enzyme-encoding genes found in the genome, and to identify the presence of reactions or pathways not indicated by current genomic data. Thus, the models can be used to guide the research and discovery process, potentially leading to the identification of new enzymes, medicines or metabolites of clinical importance.

[0019] The models of the invention are based on a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product. The reactions included in the data structure can be those that are common to all or most Homo sapiens cells, such as core metabolic reactions, or reactions specific for one or more given cell type.

[0020] As used herein, the term “Homo sapiens reaction” is intended to mean a conversion that consumes a substrate or forms a product that occurs in or by a Homo sapiens cell. The term can include a conversion that occurs due to the activity of one or more enzymes that are genetically encoded by a Homo sapiens genome. The term can also include a conversion that occurs spontaneously in a Homo sapiens cell. Conversions included in the term include, for example, changes in chemical composition such as those due to nucleophilic or electrophilic addition, nucleophilic or electrophilic substitution, elimination, isomerization, deamination, phosphorylation, methylation, reduction, oxidation or changes in location such as those that occur due to a transport reaction that moves a reactant from one cellular compartment to another. In the case of a transport reaction, the substrate and product of the reaction can be chemically the same and the substrate and product can be differentiated according to location in a particular cellular compartment. Thus, a reaction that transports a chemically unchanged reactant from a first compartment to a second compartment has as its substrate the reactant in the first compartment and as its product the reactant in the second compartment. It will be understood that when used in reference to an in silico model or data structure, a reaction is intended to be a representation of a chemical conversion that consumes a substrate or produces a product.

[0021] As used herein, the term “Homo sapiens reactant” is intended to mean a chemical that is a substrate or a product of a reaction that occurs in or by a Homo sapiens cell. The term can include substrates or products of reactions performed by one or more enzymes encoded by a Homo sapiens genome, reactions occurring in Homo sapiens that are performed by one or more non-genetically encoded macromolecule, protein or enzyme, or reactions that occur spontaneously in a Homo sapiens cell. Metabolites are understood to be reactants within the meaning of the term. It will be understood that when used in reference to an in silico model or data structure, a reactant is intended to be a representation of a chemical that is a substrate or a product of a reaction that occurs in or by a Homo sapiens cell.

[0022] As used herein the term “substrate” is intended to mean a reactant that can be converted to one or more products by a reaction. The term can include, for example, a reactant that is to be chemically changed due to nucleophilic or electrophilic addition, nucleophilic or electrophilic substitution, elimination, isomerization, deamination, phosphorylation, methylation, reduction, oxidation or that is to change location such as by being transported across a membrane or to a different compartment.

[0023] As used herein, the term “product” is intended to mean a reactant that results from a reaction with one, or more substrates. The term can include, for example, a reactant that has been chemically changed due to nucleophilic or electrophilic addition, nucleophilic or electrophilic substitution, elimination, isomerization, deamination, phosphorylation, methylation, reduction or oxidation or that has changed location such as by being transported across a membrane or to a different compartment.

[0024] As used herein, the term “stoichiometric coefficient” is intended to mean a numerical constant correlating the number of one or more reactants and the number of one or more products in a chemical reaction. Typically, the numbers are integers as they denote the number of molecules of each reactant in an elementally balanced chemical equation that describes the corresponding conversion. However, in some cases the numbers can take on non-integer values, for example, when used in a lumped reaction or to reflect empirical data.

[0025] As used herein, the term “plurality,” when used in reference to Homo sapiens reactions or reactants, is intended to mean at least 2 reactions or reactants. The term can include any number of Homo sapiens reactions or reactants in the range from 2 to the number of naturally occurring reactants or reactions for a particular of Homo sapiens cell. Thus, the term can include, for example, at least 10, 20, 30, 50, 100, 150, 200, 300, 400, 500, 600 or more reactions or reactants. The number of reactions or reactants can be expressed as a portion of the total number of naturally occurring reactions for a particular Homo sapiens cell, such as at least 20%, 30%, 50%, 60%, 75%, 90%, 95% or 98% of the total number of naturally occurring reactions that occur in a particular Homo sapiens cell.

[0026] As used herein, the term “data structure” is intended to mean a physical or logical relationship among data elements, designed to support specific data manipulation functions. The term can include, for example, a list of data elements that can be added combined or otherwise manipulated such as a list of representations for reactions from which reactants can be related in a matrix or network. The term can also include a matrix that correlates data elements from two or more lists of information such as a matrix that correlates reactants to reactions. Information included in the term can represent, for example, a substrate or product of a chemical reaction, a chemical reaction relating one or more substrates to one or more products, a constraint placed on a reaction, or a stoichiometric coefficient.

[0027] As used herein, the term “constraint” is intended to mean an upper or lower boundary for a reaction. A boundary can specify a minimum or maximum flow of mass, electrons or energy through a reaction. A boundary can further specify directionality of a reaction. A boundary can be a constant value such as zero, infinity, or a numerical value such as an integer. Alternatively, a boundary can be a variable boundary value as set forth below.

[0028] As used herein, the term “variable,” when used in reference to a constraint is intended to mean capable of assuming any of a set of values in response to being acted upon by a constraint function. The term “function,” when used in the context of a constraint, is intended to be consistent with the meaning of the term as it is understood in the computer and mathematical arts. A function can be binary such that changes correspond to a reaction being off or on. Alternatively, continuous functions can be used such that changes in boundary values correspond to increases or decreases in activity.. Such increases or decreases can also be binned or effectively digitized by a function capable of converting sets of values to discreet integer values. A function included in the term can correlate a boundary value with the presence, absence or amount of a biochemical reaction network participant such as a reactant, reaction, enzyme or gene. A function included in the term can correlate a boundary value with an outcome of at least one reaction in a reaction network that includes the reaction that is constrained by the boundary limit. A function included in the term can also correlate a boundary value with an environmental condition such as time, pH, temperature or redox potential.

[0029] As used herein, the term “activity,” when used in reference to a reaction, is intended to mean the amount of product produced by the reaction, the amount of substrate consumed by the reaction or the rate at which a product is produced or a substrate is consumed. The amount of product produced by the reaction, the amount of substrate consumed by the reaction or the rate at which a product is produced or a substrate is consumed can also be referred to as the flux for the reaction.

[0030] As used herein, the term “activity,” when used in reference to a Homo sapiens cell, is intended to mean the magnitude or rate of a change from an initial state to a final state. The term can include, for example, the amount of a chemical consumed or produced by a cell, the rate at which a chemical is consumed or produced by a cell, the amount or rate of growth of a cell or the amount of or rate at which energy, mass or electrons flow through a particular subset of reactions.

[0031] The invention provides a computer readable medium, having a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product.

[0032] Depending on the application, the plurality of Homo sapiens reactions can include reactions selected from core metabolic reactions or peripheral metabolic reactions. As used herein, the term “core,” when used in reference to a metabolic pathway, is intended to mean a metabolic pathway selected from glycolysis/gluconeogenesis, the pentose phosphate pathway (PPP), the tricarboxylic acid (TCA) cycle, glycogen storage, electron transfer system (ETS), the malate/aspartate shuttle, the glycerol phosphate shuttle, and plasma and mitochondrial membrane transporters. As used herein, the term “peripheral,” when used in reference to a metabolic pathway, is intended to mean a metabolic pathway that includes one or more reactions that are not a part of a core metabolic pathway.

[0033] A plurality of Homo sapiens reactants can be related to a plurality of Homo sapiens reactions in any data structure that represents, for each reactant, the reactions by which it is consumed or produced. Thus, the data structure, which is referred to herein as a “reaction network data structure,” serves as a representation of a biological reaction network or system. An example of a reaction network that can be represented in a reaction network data structure of the invention is the collection of reactions that constitute the core metabolic reactions of Homo sapiens, or the metabolic reactions of a skeletal muscle cell, as shown in the Examples.

[0034] The choice of reactions to include in a particular reaction network data structure, from among all the possible reactions that can occur in human cells, depends on the cell type or types and the physiological, pathological or therapeutic condition being modeled, and can be determined experimentally or from the literature, as described further below.

[0035] The reactions to be included in a particular network data structure of Homo sapiens can be determined experimentally using, for example, gene or protein expression profiles, where the molecular characteristics of the cell can be correlated to the expression levels. The expression or lack of expression of genes or proteins in a cell type can be used in determining whether a reaction is included in the model by association to the expressed gene(s) and or protein(s). Thus, it is possible to use experimental technologies to determine which genes and/or proteins are expressed in a specific cell type, and to further use this information to determine which reactions are present in the cell type of interest. In this way a subset of reactions from all of those reactions that can occur in human cells are selected to comprise the set of reactions that represent a specific cell type. cDNA expression profiles have been demonstrated to be useful, for example, for classification of breast cancer cells (Sorlie et al., Proc. Natl. Acad. Sci. U.S.A. 98(19):10869-10874 (2001)).

[0036] The methods and models of the invention can be applied to any Homo sapiens cell type at any stage of differentiation, including, for example, embryonic stem cells, hematopoietic stem cells, differentiated hematopoietic cells, skeletal muscle cells, cardiac muscle cells, smooth muscle cells, skin cells, nerve cells, kidney cells, pulmonary cells, liver cells, adipocytes and endocrine cells (e.g. beta islet cells of the pancreas, mammary gland cells, adrenal cells, and other specialized hormone secreting cells).

[0037] The methods and models of the invention can be applied to normal cells or pathological cells. Normal cells that exhibit a variety of physiological activities of interest, including homeostasis, proliferation, differentiation, apoptosis, contraction and motility, can be modeled. Pathological cells can also be modeled, including cells that reflect genetic or developmental abnormalities, nutritional deficiencies, environmental assaults, infection (such as by bacteria, viral, protozoan or fungal agents), neoplasia, aging, altered immune or endocrine function, tissue damage, or any combination of these factors. The pathological cells can be representative of any type of human pathology, including, for example, various metabolic disorders of carbohydrate, lipid or protein metabolism, obesity, diabetes, cardiovascular disease, fibrosis, various cancers, kidney failure, immune pathologies, neurodegenerative diseases, and various monogenetic metabolic diseases described in the Online Mendelian Inheritance in Man database (Center for Medical Genetics, Johns Hopkins University (Baltimore, Md.) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, Md.)).

[0038] The methods and models of the invention can also be applied to cells undergoing therapeutic perturbations, such as cells treated with drugs that target participants in a reaction network, cells treated with gene-based therapeutics that increase or decrease expression of an encoded protein, and cells treated with radiation. As used herein, the term “drug” refers to a compound of any molecular nature with a known or proposed therapeutic function, including, for example, small molecule compounds, peptides and other macromolecules, peptidomimetics and antibodies, any of which can optionally be tagged with cytostatic, targeting or detectable moieties. The term “gene-based therapeutic” refers to nucleic acid therapeutics, including, for example, expressible genes with normal or altered protein activity, antisense compounds, ribozymes, DNAzymes, RNA interference compounds (RNAi) and the like. The therapeutics can target any reaction network participant, in any cellular location, including participants in extracellular, cell surface, cytoplasmic, mitochondrial and nuclear locations. Experimental data that are gathered on the response of cells to therapeutic treatment, such as alterations in gene or protein expression profiles, can be used to tailor a network for a pathological state of a particular cell type.

[0039] The methods and models of the invention can be applied to Homo sapiens cells as they exist in any form, such as in primary cell isolates or in established cell lines, or in the whole body, in intact organs or in tissue explants. Accordingly, the methods and models can take into account intercellular communications and/or inter-organ communications, the effect of adhesion to a substrate or neighboring cells (such as a stem cell interacting with mesenchymal cells or a cancer cell interacting with its tissue microenvironment, or beta-islet cells without normal stroma), and other interactions relevant to multicellular systems.

[0040] The reactants to be used in a reaction network data structure of the invention can be obtained from or stored in a compound database. As used herein, the term “compound database” is intended to mean a computer readable medium or media containing a plurality of molecules that includes substrates and products of biological reactions. The plurality of molecules can include molecules found in multiple organisms, thereby constituting a universal compound database. Alternatively, the plurality of molecules can be limited to those that occur in a particular organism, thereby constituting an organism-specific compound database. Each reactant in a compound database can be identified according to the chemical species and the cellular compartment in which it is present. Thus, for example, a distinction can be made between glucose in the extracellular compartment versus glucose in the cytosol. Additionally each of the reactants can be specified as a metabolite of a primary or secondary metabolic pathway. Although identification of a reactant as a metabolite of a primary or secondary metabolic pathway does not indicate any chemical distinction between the reactants in a reaction, such a designation can assist in visual representations of large networks of reactions.

[0041] As used herein, the term “compartment” is intended to mean a subdivided region containing at least one reactant, such that the reactant is separated from at least one other reactant in a second region. A subdivided region included in the term can be correlated with a subdivided region of a cell. Thus, a subdivided region included in the term can be, for example, the intracellular space of a cell; the extracellular space around a cell; the periplasmic space, the interior space of an organelle such as a mitochondrium, endoplasmic reticulum, Golgi apparatus, vacuole or nucleus; or any subcellular space that is separated from another by a membrane or other physical barrier. Subdivided regions can also be made in order to create virtual boundaries in a reaction network that are not correlated with physical barriers. Virtual boundaries can be made for the purpose of segmenting the reactions in a network into different compartments or substructures.

[0042] As used herein, the term “substructure” is intended to mean a portion of the information in a data structure that is separated from other information in the data structure such that the portion of information can be separately manipulated or analyzed. The term can include portions subdivided according to a biological function including, for example, information relevant to a particular metabolic pathway such as an internal flux pathway, exchange flux pathway, central metabolic pathway, peripheral metabolic pathway, or secondary metabolic pathway. The term can include portions subdivided according to computational or mathematical principles that allow for a particular type of analysis or manipulation of the data structure.

[0043] The reactions included in a reaction network data structure can be obtained from a metabolic reaction database that includes the substrates, products, and stoichiometry of a plurality of metabolic reactions of Homo sapiens. The reactants in a reaction network data structure can be designated as either substrates or products of a particular reaction, each with a stoichiometric coefficient assigned to it to describe the chemical conversion taking place in the reaction. Each reaction is also described as occurring in either a reversible or irreversible direction. Reversible reactions can either be represented as one reaction that operates in both the forward and reverse direction or be decomposed into two irreversible reactions, one corresponding to the forward reaction and the other corresponding to the backward reaction.

[0044] Reactions included in a reaction network data structure can include intra-system or exchange reactions. Intra-system reactions are the chemically and electrically balanced interconversions of chemical species and transport processes, which serve to replenish or drain the relative amounts of certain metabolites. These intra-system reactions can be classified as either being transformations or translocations. A transformation is a reaction that contains distinct sets of compounds as substrates and products, while a translocation contains reactants located in different compartments. Thus a reaction that simply transports a metabolite from the extracellular environment to the cytosol, without changing its chemical composition is solely classified as a translocation, while a reaction that takes an extracellular substrate and converts it into a cytosolic product is both a translocation and a transformation.

[0045] Exchange reactions are those which constitute sources and sinks, allowing the passage of metabolites into and out of a compartment or across a hypothetical system boundary. These reactions are included in a model for simulation purposes and represent the metabolic demands placed on Homo sapiens. While they may be chemically balanced in certain cases, they are typically not balanced and can often have only a single substrate or product. As a matter of convention the exchange reactions are further classified into demand exchange and input/output exchange reactions.

[0046] The metabolic demands placed on the Homo sapiens metabolic reaction network can be readily determined from the dry weight composition of the cell which is available in the published literature or which can be determined experimentally. The uptake rates and maintenance requirements for Homo sapiens cells can also be obtained from the published literature or determined experimentally.

[0047] Input/output exchange reactions are used to allow extracellular reactants to enter or exit the reaction network represented by a model of the invention. For each of the extracellular metabolites a corresponding input/output exchange reaction can be created. These reactions are always reversible with the metabolite indicated as a substrate with a stoichiometric coefficient of one and no products produced by the reaction. This particular convention is adopted to allow the reaction to take on a positive flux value (activity level) when the metabolite is being produced or removed from the reaction network and a negative flux value when the metabolite is being consumed or introduced into the reaction network. These reactions will be further constrained during the course of a simulation to specify exactly which metabolites are available to the cell and which can be excreted by the cell.

[0048] A demand exchange reaction is always specified as an irreversible reaction containing at least one substrate. These reactions are typically formulated to represent the production of an intracellular metabolite by the metabolic network or the aggregate production of many reactants in balanced ratios such as in the representation of a reaction that leads to biomass formation, also referred to as growth.

[0049] A demand exchange reactions can be introduced for any metabolite in a model of the invention. Most commonly these reactions are introduced for metabolites that are required to be produced by the cell for the purposes of creating a new cell such as amino acids, nucleotides, phospholipids, and other biomass constituents, or metabolites that are to be produced for alternative purposes. Once these metabolites are identified, a demand exchange reaction that is irreversible and specifies the metabolite as a substrate with a stoichiometric coefficient of unity can be created. With these specifications, if the reaction is active it leads to the net production of the metabolite by the system meeting potential production demands. Examples of processes that can be represented as a demand exchange reaction in a reaction network data structure and analyzed by the methods of the invention include, for example, production or secretion of an individual protein; production or secretion of an individual metabolite such as an amino acid, vitamin, nucleoside, antibiotic or surfactant; production of ATP for extraneous energy requiring processes such as locomotion; or formation of biomass constituents.

[0050] In addition to these demand exchange reactions that are placed on individual metabolites, demand exchange reactions that utilize multiple metabolites in defined stoichiometric ratios can be introduced. These reactions are referred to as aggregate demand exchange reactions. An example of an aggregate demand reaction is a reaction used to simulate the concurrent growth demands or production requirements associated with cell growth that are placed on a cell, for example, by simulating the formation of multiple biomass constituents simultaneously at a particular cellular growth rate.

[0051] A hypothetical reaction network is provided in FIG. 1 to exemplify the above-described reactions and their interactions. The reactions can be represented in the exemplary data structure shown in FIG. 3 as set forth below. The reaction network, shown in FIG. 1, includes intrasystem reactions that occur entirely within the compartment indicated by the shaded oval such as reversible reaction R2 which acts on reactants B and G and reaction R3 which converts one equivalent of B to 2 equivalents of F. The reaction network shown in FIG. 1 also contains exchange reactions such as input/output exchange reactions Axt and Ext, and the demand exchange reaction, Vgrowth, which represents growth in response to the one equivalent of D and one equivalent of F. Other intrasystem reactions include R1 which is a translocation and transformation reaction that translocates reactant A into the compartment and transforms it to reactant G and reaction R6 which is a transport reaction that translocates reactant E out of the compartment.

[0052] A reaction network can be represented as a set of linear algebraic equations which can be presented as a stoichiometric matrix S, with S being an m x n matrix where m corresponds to the number of reactants or metabolites and n corresponds to the number of reactions taking place in the network. An example of a stoichiometric matrix representing the reaction network of FIG. 1 is shown in FIG. 3. As shown in FIG. 3, each column in the matrix corresponds to a particular reaction n, each row corresponds to a particular reactant m, and each Smn element corresponds to the stoichiometric coefficient of the reactant m in the reaction denoted n. The stoichiometric matrix includes intra-system reactions such as R2 and R3 which are related to reactants that participate in the respective reactions according to a stoichiometric coefficient having a sign indicative of whether the reactant is a substrate or product of the reaction and a value correlated with the number of equivalents of the reactant consumed or produced by the reaction. Exchange reactions such as −Ext and −Axt are similarly correlated with a stoichiometric coefficient. As exemplified by reactant E, the same compound can be treated separately as an internal reactant (E) and an external reactant (Eexternal) such that an exchange reaction (R6) exporting the compound is correlated by stoichiometric coefficients of −1 and 1, respectively. However, because the compound is treated as a separate reactant by virtue of its compartmental location, a reaction, such as R5, which produces the internal reactant (E) but does not act on the external reactant (Eexternal) is correlated by stoichiometric coefficients of 1 and 0, respectively. Demand reactions such as Vgrowth can also be included in the stoichiometric matrix being correlated with substrates by an appropriate stoichiometric coefficient.

[0053] As set forth in further detail below, a stoichiometric matrix provides a convenient format for representing and analyzing a reaction network because it can be readily manipulated and used to compute network properties, for example, by using linear programming or general convex analysis. A reaction network data structure can take on a variety of formats so long as it is capable of relating reactants and reactions in the manner exemplified above for a stoichiometric matrix and in a manner that can be manipulated to determine an activity of one or more reactions using methods such as those exemplified below. Other examples of reaction network data structures that are useful in the invention include a connected graph, list of chemical reactions or a table of reaction equations.

[0054] A reaction network data structure can be constructed to include all reactions that are involved in Homo sapiens metabolism or any portion thereof. A portion of Homo sapiens metabolic reactions that can be included in a reaction network data structure of the invention includes, for example, a central metabolic pathway such as glycolysis, the TCA cycle, the PPP or ETS; or a peripheral metabolic pathway such as amino acid biosynthesis, amino acid degradation, purine biosynthesis, pyrimidine biosynthesis, lipid biosynthesis, fatty acid metabolism, vitamin or cofactor biosynthesis, transport processes and alternative carbon source catabolism. Examples of individual pathways within the peripheral pathways are set forth in Table 1.

[0055] Depending upon a particular application, a reaction network data structure can include a plurality of Homo sapiens reactions including any or all of the reactions listed in Table 1.

[0056] For some applications, it can be advantageous to use a reaction network data structure that includes a minimal number of reactions to achieve a particular Homo sapiens activity under a particular set of environmental conditions. A reaction network data structure having a minimal number of reactions can be identified by performing the simulation methods described below in an iterative fashion where different reactions or sets of reactions are systematically removed and the effects observed. Accordingly, the invention provides a computer readable medium, containing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein the plurality of Homo sapiens reactions contains at least 65 reactions. For example, the core metabolic reaction database shown in Tables 2 and 3 contains 65 reactions, and is sufficient to simulate aerobic and anaerobic metabolism on a number of carbon sources, including glucose.

[0057] Depending upon the particular cell type or types, the physiological, pathological or therapeutic conditions being tested and the desired activity, a reaction network data structure can contain smaller numbers of reactions such as at least 200, 150, 100 or 50 reactions. A reaction network data structure having relatively few reactions can provide the advantage of reducing computation time and resources required to perform a simulation. When desired, a reaction network data structure having a particular subset of reactions can be made or used in which reactions that are not relevant to the particular simulation are omitted. Alternatively, larger numbers of reactions can be included in order to increase the accuracy or molecular detail of the methods of the invention or to suit a particular application. Thus, a reaction network data structure can contain at least 300, 350, 400, 450, 500, 550, 600 or more reactions up to the number of reactions that occur in or by Homo sapiens or that are desired to simulate the activity of the full set of reactions occurring in Homo sapiens. A reaction network data structure that is substantially complete with respect to the metabolic reactions of Homo sapiens provides the advantage of being relevant to a wide range of conditions to be simulated, whereas those with smaller numbers of metabolic reactions are limited to a particular subset of conditions to be simulated.

[0058] A Homo sapiens reaction network data structure can include one or more reactions that occur in or by Homo sapiens and that do not occur, either naturally or following manipulation, in or by another organism, such as Saccharomiyces cerevisiae. It is understood that a Homo sapiens reaction network data structure of a particular cell type can also include one or more reactions that occur in another cell type. Addition of such heterologous reactions to a reaction network data structure of the invention can be used in methods to predict the consequences of heterologous gene transfer and protein expression, for example, when designing in vivo and ex vivo gene therapy approaches.

[0059] The reactions included in a reaction network data structure of the invention can be metabolic reactions. A reaction network data structure can also be constructed to include other types of reactions such as regulatory reactions, signal transduction reactions, cell cycle reactions, reactions controlling developmental processes, reactions involved in apoptosis, reactions involved in responses to hypoxia, reactions involved in responses to cell-cell or cell-substrate interactions, reactions involved in protein synthesis and regulation thereof, reactions involved in gene transcription and translation, and regulation thereof, and reactions involved in assembly of a cell and its subcellular components.

[0060] A reaction network data structure or index of reactions used in the data structure such as that available in a metabolic reaction database, as described above, can be annotated to include information about a particular reaction. A reaction can be annotated to indicate, for example, assignment of the reaction to a protein, macromolecule or enzyme that performs the reaction, assignment of a gene(s) that codes for the protein, macromolecule or enzyme, the Enzyme Commission (EC) number of the particular metabolic reaction, a subset of reactions to which the reaction belongs, citations to references from which information was obtained, or a level of confidence with which a reaction is believed to occur in Homo sapiens. A computer readable medium or media of the invention can include a gene database containing annotated reactions. Such information can be obtained during the course of building a metabolic reaction database or model of the invention as described below.

[0061] As used herein, the term “gene database” is intended to mean a computer readable medium or media that contains at least one reaction that is annotated to assign a reaction to one or more macromolecules that perform the reaction or to assign one or more nucleic acid that encodes the one or more macromolecules that perform the reaction. A gene database can contain a plurality of reactions, some or all of which are annotated. An annotation can include, for example, a name for a macromolecule; assignment of a function to a macromolecule; assignment of an organism that contains the macromolecule or produces the macromolecule; assignment of a subcellular location for the macromolecule; assignment of conditions under which a macromolecule is regulated with respect to performing a reaction, being expressed or being degraded; assignment of a cellular component that regulates a macromolecule; an amino acid or nucleotide sequence for the macromolecule; or any other annotation found for a macromolecule in a genome database such as those that can be found in Genbank, a site maintained by the NCBI (ncbi.nlm.gov), the Kyoto Encyclopedia of Genes and Genomes (KEGG) (www.genome.ad.jp/kegg/), the protein database SWISS-PROT (ca.expasy.org/sprot/), the LocusLink database maintained by the NCBI (www.ncbi.nlm.nih.gov/LocusLink/), the Enzyme Nomenclature database maintained by G. P. Moss of Queen Mary and Westfield College in the United Kingdom (www.chem.qmw.ac.uk/iubmb/enzyme/).

[0062] A gene database of the invention can include a substantially complete collection of genes or open reading frames in Homo sapiens or a substantially complete collection of the macromolecules encoded by the Homo sapiens genome. Alternatively, a gene database can include a portion of genes or open reading frames in Homo sapiens or a portion of the macromolecules encoded by the Homo sapiens genome, such as the portion that includes substantially all metabolic genes or macromolecules. The portion can be at least 10%, 15%, 20%, 25%, 50%, 75%, 90% or 95% of the genes or open reading frames encoded by the Homo sapiens genome, or the macromolecules encoded therein. A gene database can also include macromolecules encoded by at least a portion of the nucleotide sequence for the Homo sapiens genome such as at least 10%, 15%, 20%, 25%, 50%, 75%, 90% or 95% of the Homo sapiens genome. Accordingly, a computer readable medium or media of the invention can include at least one reaction for each macromolecule encoded by a portion of the Homo sapiens genome.

[0063] An in silico Homo sapiens model of the invention can be built by an iterative process which includes gathering information regarding particular reactions to be added to a model, representing the reactions in a reaction network data structure, and performing preliminary simulations wherein a set of constraints is placed on the reaction network and the output evaluated to identify errors in the network. Errors in the network such as gaps that lead to non-natural accumulation or consumption of a particular metabolite can be identified as described below and simulations repeated until a desired performance of the model is attained. An exemplary method for iterative model construction is provided in Example I.

[0064] Thus, the invention provides a method for making a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions in a computer readable medium or media. The method includes the steps of: (a) identifying a plurality of Homo sapiens reactions and a plurality of Homo sapiens reactants that are substrates and products of the Homo sapiens reactions; (by relating the plurality of Homo sapiens reactants to the plurality of Homo sapiens reactions in a data structure, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product; (c) making a constraint set for the plurality of Homo sapiens reactions; (d) providing an objective function; (e) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, and (f) if the at least one flux distribution is not predictive of Homo sapiens physiology, then adding a reaction to or deleting a reaction from the data structure and repeating step (e), if the at least one flux distribution is predictive of Homo sapiens physiology, then storing the data structure in a computer readable medium or media.

[0065] Information to be included in a data structure of the invention can be gathered from a variety of sources including, for example, annotated genome sequence information and biochemical literature.

[0066] Sources of annotated human genome sequence information include, for example, KEGG, SWISS-PROT, LocusLink, the Enzyme Nomenclature database, the International Human Genome Sequencing Consortium and commercial databases. KEGG contains a broad range of information, including a substantial amount of metabolic reconstruction. The genomes of 63 organisms can be accessed here, with gene products grouped by coordinated functions, often represented by a map (e.g., the enzymes involved in glycolysis would be grouped together). The maps are biochemical pathway templates which show enzymes connecting metabolites for various parts of metabolism. These general pathway templates are customized for a given organism by highlighting enzymes on a given template which have been identified in the genome of the organism. Enzymes and metabolites are active and yield useful information about stoichiometry, structure, alternative names and the like, when accessed.

[0067] SWISS-PROT contains detailed information about protein function. Accessible information includes alternate gene and gene product names, function, structure and sequence information, relevant literature references, and the like.

[0068] LocusLink contains general information about the locus where the gene is located and, of relevance, tissue specificity, cellular location, and implication of the gene product in various disease states.

[0069] The Enzyme Nomenclature database can be used to compare the gene products of two organisms. Often the gene names for genes with similar functions in two or more organisms are unrelated. When this is the case, the E. C. (Enzyme Commission) numbers can be used as unambiguous indicators of gene product function. The information in the Enzyme Nomenclature database is also published in Enzyme Nomenclature (Academic Press, San Diego, Calif., 1992) with 5 supplements to date, all found in the European Journal of Biochemistry (Blackwell Science, Malden, Mass.).

[0070] Sources of biochemical information include, for example, general resources relating to metabolism, resources relating specifically to human metabolism, and resources relating to the biochemistry, physiology and pathology of specific human cell types.

[0071] Sources of general information relating to metabolism, which were used to generate the human reaction databases and models described herein, were J. G. Salway, Metabolism at a Glance, 2nd ed., Blackwell Science, Malden, Mass. (1999) and T. M. Devlin, ed., Textbook of Biochemistry with Clinical Correlations, 4th ed., John Wiley and Sons, New York, NY (1997). Human metabolism-specific resources included J. R. Bronk, Human Metabolism: Functional Diversity and Integration, Addison Wesley Longman, Essex, England (1999).

[0072] The literature used in conjunction with the skeletal muscle metabolic models and simulations described herein included R. Maughan et al., Biochemistry of Exercise and Training, Oxford University Press, Oxford, England (1997), as well as references on muscle pathology such as S. Carpenter et al., Pathology of Skeletal Muscle, 2nd ed., Oxford University Press, Oxford, England (2001), and more specific articles on muscle metabolism as may be found in the Journal of Physiology (Cambridge University Press, Cambridge, England).

[0073] In the course of developing an in silico model of Homo sapiens metabolism, the types of data that can be considered include, for example, biochemical information which is information related to the experimental characterization of a chemical reaction, often directly indicating a protein(s) associated with a reaction and the stoichiometry of the reaction or indirectly demonstrating the existence of a reaction occurring within a cellular extract; genetic information, which is information related to the experimental identification and genetic characterization of a gene(s) shown to code for a particular protein(s) implicated in carrying out a biochemical event; genomic information, which is information related to the identification of an open reading frame and functional assignment, through computational sequence analysis, that is then linked to a protein performing a biochemical event; physiological information, which is information related to overall cellular physiology, fitness characteristics, substrate utilization, and phenotyping results, which provide evidence of the assimilation or dissimilation of a compound used to infer the presence of specific biochemical event (in particular translocations); and modeling information, which is information generated through the course of simulating activity of Homo sapiens cells using methods such as those described herein which lead to predictions regarding the status of a reaction such as whether or not the reaction is required to fulfill certain demands placed on a metabolic network. Additional information relevant to multicellular organisms that can be considered includes cell type-specific or condition-specific gene expression information, which can be determined experimentally, such as by gene array analysis or from expressed sequence tag (EST) analysis, or obtained from the biochemical and physiological literature.

[0074] The majority of the reactions occurring in Homo sapiens reaction networks are catalyzed by enzymes/proteins, which are created through the transcription and translation of the genes found within the chromosome in the cell. The remaining reactions occur either spontaneously or through non-enzymatic processes. Furthermore, a reaction network data structure can contain reactions that add or delete steps to or from a particular reaction pathway. For example, reactions can be added to optimize or improve performance of a Homo sapiens model in view of empirically observed activity. Alternatively, reactions can be deleted to remove intermediate steps in a pathway when the intermediate steps are not necessary to model flux through the pathway. For example, if a pathway contains 3 nonbranched steps, the reactions can be combined or added together to give a net reaction, thereby reducing memory required to store the reaction network data structure and the computational resources required for manipulation of the data structure.

[0075] The reactions that occur due to the activity of gene-encoded enzymes can be obtained from a genome database which lists genes identified from genome sequencing and subsequent genome annotation. Genome annotation consists of the locations of open reading frames and assignment of function from homology to other known genes or empirically determined activity. Such a genome database can be acquired through public or private databases containing annotated Homo sapiens nucleic acid or protein sequences. If desired, a model developer can perform a network reconstruction and establish the model content associations between the genes, proteins, and reactions as described, for example, in Covert et al. Trends in Biochemical Sciences 26:179-186 (2001) and Palsson, WO 00/46405.

[0076] As reactions are added to a reaction network data structure or metabolic reaction database, those having known or putative associations to the proteins/enzymes which enable/catalyze the reaction and the associated genes that code for these proteins can be identified by annotation. Accordingly, the appropriate associations for all of the reactions to their related proteins or genes or both can be assigned. These associations can be used to capture the non-linear relationship between the genes and proteins as well as between proteins and reactions. In some cases one gene codes for one protein which then perform one reaction. However, often there are multiple genes which are required to create an active enzyme complex and often there are multiple reactions that can be carried out by one protein or multiple proteins that can carry out the same reaction. These associations capture the logic (i.e. AND or OR relationships) within the associations. Annotating a metabolic reaction database with these associations can allow the methods to be used to determine the effects of adding or eliminating a particular reaction not only at the reaction level, but at the genetic or protein level in the context of running a simulation or predicting Homo sapiens activity.

[0077] A reaction network data structure of the invention can be used to determine the activity of one or more reactions in a plurality of Homo sapiens reactions independent of any knowledge or annotation of the identity of the protein that performs the reaction or the gene encoding the protein. A model that is annotated with gene or protein identities can include reactions for which a protein or encoding gene is not assigned. While a large portion of the reactions in a cellular metabolic network are associated with genes in the organism's genome, there are also a substantial number of reactions included in a model for which there are no known genetic associations. Such reactions can be added to a reaction database based upon other information that is not necessarily related to genetics such as biochemical or cell based measurements or theoretical considerations based on observed biochemical or cellular activity. For example, there are many reactions that can either occur spontaneously or are not protein-enabled reactions. Furthermore, the occurrence of a particular reaction in a cell for which no associated proteins or genetics have been currently identified can be indicated during the course of model building by the iterative model building methods of the invention.

[0078] The reactions in a reaction network data structure or reaction database can be assigned to subsystems by annotation, if desired. The reactions can be subdivided according to biological criteria, such as according to traditionally identified metabolic pathways (glycolysis, amino acid metabolism and the like) or according to mathematical or computational criteria that facilitate manipulation of a model that incorporates or manipulates the reactions. Methods and criteria for subdviding a reaction database are described in further detail in Schilling et al., J. Theor. Biol. 203:249-283 (2000), and in Schuster et al., Bioinformatics 18:351-361 (2002). The use of subsystems can be advantageous for a number of analysis methods, such as extreme pathway analysis, and can make the management of model content easier. Although assigning reactions to subsystems can be achieved without affecting the use of the entire model for simulation, assigning reactions to subsystems can allow a user to search for reactions in a particular subsystem which may be useful in performing various types of analyses. Therefore, a reaction network data structure can include any number of desired subsystems including, for example, 2 or more subsystems, 5 or more subsystems, 10 or more subsystems, 25 or more subsystems or 50 or more subsystems.

[0079] The reactions in a reaction network data structure or metabolic reaction database can be annotated with a value indicating the confidence with which the reaction is believed to occur in the Homo sapiens cell. The level of confidence can be, for example, a function of the amount and form of supporting data that is available. This data can come in various forms including published literature, documented experimental results, or results of computational analyses. Furthermore, the data can provide direct or indirect evidence for the existence of a chemical reaction in a cell based on genetic, biochemical, and/or physiological data.

[0080] The invention further provides a computer readable medium, containing (a) a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product, and (b) a constraint set for the plurality of Homo sapiens reactions.

[0081] Constraints can be placed on the value of any of the fluxes in the metabolic network using a constraint set. These constraints can be representative of a minimum or maximum allowable flux through a given reaction, possibly resulting from a limited amount of an enzyme present. Additionally, the constraints can determine the direction or reversibility of any of the reactions or transport fluxes in the reaction network data structure. Based on the in vivo environment where Homo sapiens lives the metabolic resources available to the cell for biosynthesis of essential molecules for can be determined. Allowing the corresponding transport fluxes to be active provides the in silico Homo sapiens with inputs and outputs for substrates and by-products produced by the metabolic network.

[0082] Returning to the hypothetical reaction network shown in FIG. 1, constraints can-be placed on each reaction in the exemplary format shown in FIG. 2, as follows. The constraints are provided in a format that can be used to constrain the reactions of the stoichiometric matrix shown in FIG. 3. The format for the constraints used for a matrix or in linear programming can be conveniently represented as a linear inequality such as

b

j

≦v

j

≦a

j

:j
=1. . . n (Eq. 1)

[0083] where vj is the metabolic flux vector, bj is the minimum flux value and aj is the maximum flux value. Thus, aj can take on a finite value representing a maximum allowable flux through a given reaction or bj can take on a finite value representing minimum allowable flux through a given reaction. Additionally, if one chooses to leave certain reversible reactions or transport fluxes to operate in a forward and reverse manner the flux may remain unconstrained by setting bj to negative infinity and aj to positive infinity as shown for reaction R2 in FIG. 2. If reactions proceed only in the forward reaction bj is set to zero while aj is set to positive infinity as shown for reactions R1, R3, R4, R5, and R6 in FIG. 2. As an example, to simulate the event of a genetic deletion or non-expression of a particular protein, the flux through all of the corresponding metabolic reactions related to the gene or protein in question are reduced to zero by setting aj and bj to be zero. Furthermore, if one wishes to simulate the absence of a particular growth substrate one can simply constrain the corresponding transport fluxes that allow the metabolite to enter the cell to be zero by setting aj and bj to be zero. On the other hand if a substrate is only allowed to enter or exit the cell via transport mechanisms, the corresponding fluxes can be properly constrained to reflect this scenario.

[0084] The ability of a reaction to be actively occurring is dependent on a large number of additional factors beyond just the availability of substrates. These factors, which can be represented as variable constraints in the models and methods of the invention include, for example, the presence of cofactors necessary to stabilize the protein/enzyme, the presence or absence of enzymatic inhibition and activation factors, the active formation of the protein/enzyme through translation of the corresponding mRNA transcript, the transcription of the associated gene(s) or the presence of chemical signals and/or proteins that assist in controlling these processes that ultimately determine whether a chemical reaction is capable of being carried out within an organism. Of particular importance in the regulation of human cell types is the implementation of paracrine and endocrine signaling pathways to control cellular activities. In these cases a cell secretes signaling molecules that may be carried far afield to act on distant targets (endocrine signaling), or act as local mediators (paracrine signaling). Examples of endocrine signaling molecules include hormones such as insulin, while examples of paracrine signaling molecules include neurotransmitters such as acetylcholine. These molecules induce cellular responses through signaling cascades that affect the activity of biochemical reactions in the cell.

[0085] Regulation can be represented in an in silico Homo sapiens model by providing a variable constraint as set forth below.

[0086] Thus, the invention provides a computer readable medium or media, including (a) a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product, and wherein at least one of the reactions is a regulated reaction; and (b) a constraint set for the plurality of reactions, wherein the constraint set includes a variable constraint for the regulated reaction.

[0087] As used herein, the term “regulated,” when used in reference to a reaction in a data structure, is intended to mean a reaction that experiences an altered flux due to a change in the value of a constraint or a reaction that has a variable constraint.

[0088] As used herein, the term “regulatory reaction” is intended to mean a chemical conversion or interaction that alters the activity of a protein, macromolecule or enzyme. A chemical conversion or interaction can directly alter the activity of a protein, macromolecule or enzyme such as occurs when the protein, macromolecule or enzyme is post-translationally modified or can indirectly alter the activity of a protein, macromolecule or enzyme such as occurs when a chemical conversion or binding event leads to altered expression of the protein, macromolecule or enzyme. Thus, transcriptional or translational regulatory pathways can indirectly alter a protein, macromolecule or enzyme or an associated reaction. Similarly, indirect regulatory reactions can include reactions that occur due to downstream components or participants in a regulatory reaction network. When used in reference to a data structure or in silico Homo sapiens model, the term is intended to mean a first reaction that is related to a second reaction by a function that alters the flux through the second reaction by changing the value of a constraint on the second reaction.

[0089] As used herein, the term “regulatory data structure” is intended to mean a representation of an event, reaction or network of reactions that activate or inhibit a reaction, the representation being in a format that can be manipulated or analyzed. An event that activates a reaction can be an event that initiates the reaction or an event that increases the rate or level of activity for the reaction. An event that inhibits a reaction can be an event that stops the reaction or an event that decreases the rate or level of activity for the reaction. Reactions that can be represented in a regulatory data structure include, for example, reactions that control expression of a macromolecule that in turn, performs a reaction such as transcription and translation reactions, reactions that lead to post translational modification of a protein or enzyme such as phophorylation, dephosphorylation, prenylation, methylation, oxidation or covalent modification, reactions that process a protein or enzyme such as removal of a pre- or pro-sequence, reactions that degrade a protein or enzyme or reactions that lead to assembly of a protein or enzyme.

[0090] As used herein, the term “regulatory event” is intended to mean a modifier of the flux through a reaction that is independent of the amount of reactants available to the reaction. A modification included in the term can be a change in the presence, absence, or amount of an enzyme that performs a reaction. A modifier included in the term can be a regulatory reaction such as a signal transduction reaction or an environmental condition such as a change in pH, temperature, redox potential or time. It will be understood that when used in reference to an in silico Homo sapiens model or data structure a regulatory event is intended to be a representation of a modifier of the flux through a Homo sapiens reaction that is independent of the amount of reactants available to the reaction.

[0091] The effects of regulation on one or more reactions that occur in Homo sapiens can be predicted using an in silica Homo sapiens model of the invention. Regulation can be taken into consideration in the context of a particular condition being examined by providing a variable constraint for the reaction in an in silico Homo sapiens model. Such constraints constitute condition-dependent constraints. A data structure can represent regulatory reactions as Boolean logic statements (Reg-reaction). The variable takes on a value of 1 when the reaction is available for use in the reaction network and will take on a value of 0 if the reaction is restrained due to some regulatory feature. A series of Boolean statements can then be introduced to mathematically represent the regulatory network as described for example in Covert et al. J. Theor. Biol. 213:73-88 (2001). For example, in the case of a transport reaction (A_in) that imports metabolite A, where metabolite A inhibits reaction R2 as shown in FIG. 4, a Boolean rule can state that:

Reg−R2=IF NOT(A_in) (Eq. 2)

[0092] This statement indicates that reaction R2 can occur if reaction A_in is not occurring (i.e. if metabolite A is not present). Similarly, it is possible to assign the regulation to a variable A which would indicate an amount of A above or below a threshold that leads to the inhibition of reaction R2. Any function that provides values for variables corresponding to each of the reactions in the biochemical reaction network can be used to represent a regulatory reaction or set of regulatory reactions in a regulatory data structure. Such functions can include, for example, fuzzy logic, heuristic rule-based descriptions, differential equations or kinetic equations detailing system dynamics.

[0093] A reaction constraint placed on a reaction can be incorporated into an in silico Homo sapiens model using the following general equation:

(Reg-Reaction) * bj≦vj≦aj* (Reg-Reaction) (Eq. 3)

[0094] j=1 . . . n

[0095] For the example of reaction R2 this equation is written as follows:

(0)*Reg−R2≦R2≦(∞)·Reg−R2 (Eq. 4)

[0096] Thus, during the course of a simulation, depending upon the presence or absence of metabolite A in the interior of the cell where reaction R2 occurs, the value for the upper boundary of flux for reaction R2 will change from 0 to infinity, respectively.

[0097] With the effects of a regulatory event or network taken into consideration by a constraint function and the condition-dependent constraints set to an initial relevant value, the behavior of the Homo sapiens reaction network can be simulated for the conditions considered as set forth below.

[0098] Although regulation has been exemplified above for the case where a variable constraint is dependent upon the outcome of a reaction in the data structure, a plurality of variable constraints can be included in an in silico Homo sapiens model to represent regulation of a plurality of reactions. Furthermore, in the exemplary case set forth above, the regulatory structure includes a general control stating that a reaction is inhibited by a particular environmental condition. Using a general control of this type, it is possible to incorporate molecular mechanisms and additional detail into the regulatory structure that is responsible for determining the active nature of a particular chemical reaction within an organism.

[0099] Regulation can also be simulated by a model of the invention and used to predict a Homo sapiens physiological function without knowledge of the precise molecular mechanisms involved in the reaction network being modeled. Thus, the model can be used to predict, in silico, overall regulatory events or causal relationships that are not apparent from in vivo observation of any one reaction in a network or whose in vivo effects on a particular reaction are not known. Such overall regulatory effects can include those that result from overall environmental conditions such as changes in pH, temperature, redox potential, or the passage of time.

[0100] The in silico Homo sapiens model and methods described herein can be implemented on any conventional host computer system, such as those based on Intel.RTM. microprocessors and running Microsoft Windows operating systems. Other systems, such as those using the UNIX or LINUX operating system and based on IBM.RTM., DEC.RTM. or Motorola.RTM. microprocessors are also contemplated. The systems and methods described herein can also be implemented to run on client-server systems and wide-area networks, such as the Internet.

[0101] Software to implement a method or model of the invention can be written in any well-known computer language, such as Java, C, C++, Visual Basic, FORTRAN or COBOL and compiled using any well-known compatible compiler. The software of the invention normally runs from instructions stored in a memory on a host computer system. A memory or computer readable medium can be a hard disk, floppy disc, compact disc, magneto-optical disc, Random Access Memory, Read Only Memory or Flash Memory. The memory or computer readable medium used in the invention can be contained within a single computer or distributed in a network. A network can be any of a number of conventional network systems known in the art such as a local area network (LAN) or a wide area network (WAN). Client-server environments, database servers and networks that can be used in the invention are well known in the art. For example, the database server can run on an operating system such as UNIX, running a relational database management system, a World Wide Web application and a World Wide Web server. Other types of memories and computer readable media are also contemplated to function within the scope of the invention.

[0102] A database or data structure of the invention can be represented in a markup language format including, for example, Standard Generalized Markup Language (SGML), Hypertext markup language (HTML) or Extensible Markup language (XML). Markup languages can be used to tag the information stored in a database or data structure of the invention, thereby providing convenient annotation and transfer of data between databases and data structures. In particular, an XML format can be useful for structuring the data representation of reactions, reactants and their annotations; for exchanging database contents, for example, over a network or internet; for updating individual elements using the document object model; or for providing differential access to multiple users for different information content of a data base or data structure of the invention. XML programming methods and editors for writing XML code are known in the art as described, for example, in Ray, “Learning XML” O'Reilly and Associates, Sebastopol, Calif. (2001).

[0103] A set of constraints can be applied to a reaction network data structure to simulate the flux of mass through the reaction network under a particular set of environmental conditions specified by a constraints set. Because the time constants characterizing metabolic transients and/or metabolic reactions are typically very rapid, on the order of milli-seconds to seconds, compared to the time constants of cell growth on the order of hours to days, the transient mass balances can be simplified to only consider the steady state behavior. Referring now to an example where the reaction network data structure is a stoichiometric matrix, the steady state mass balances can be applied using the following system of linear equations

S·v=
0 (Eq. 5)

[0104] where S is the stoichiometric matrix as defined above and v is the flux vector. This equation defines the mass, energy, and redox potential constraints placed on the metabolic network as a result of stoichiometry. Together Equations 1 and 5 representing the reaction constraints and mass balances, respectively, effectively define the capabilities and constraints of the metabolic genotype and the organism's metabolic potential. All vectors, v, that satisfy Equation 5 are said to occur in the mathematical nullspace of S. Thus, the null space defines steady-state metabolic flux distributions that do not violate the mass, energy, or redox balance constraints. Typically, the number of fluxes is greater than the number of mass balance constraints, thus a plurality of flux distributions satisfy the mass balance constraints and occupy the null space. The null space, which defines the feasible set of metabolic flux distributions, is further reduced in size by applying the reaction constraints set forth in Equation 1 leading to a defined solution space. A point in this space represents a flux distribution and hence a metabolic phenotype for the network. An optimal solution within the set of all solutions can be determined using mathematical optimization methods when provided with a stated objective and a constraint set. The calculation of any solution constitutes a simulation of the model.

[0105] Objectives for activity of a human cell can be chosen. While the overall objective of a multi-cellular organism may be growth or reproduction, individual human cell types generally have much more complex objectives, even to the seemingly extreme objective of apoptosis (programmed cell death), which may benefit the organism but certainly not the individual cell. For example, certain cell types may have the objective of maximizing energy production, while others have the objective of maximizing the production of a particular hormone, extracellular matrix component, or a mechanical property such as contractile force. In cases where cell reproduction is slow, such as human skeletal muscle, growth and its effects need not be taken into account. In other cases, biomass composition and growth rate could be incorporated into a “maintenance” type of flux, where rather than optimizing for growth, production of precursors is set at a level consistent with experimental knowledge and a different objective is optimized.

[0106] Certain cell types, including cancer cells, can be viewed as having an objective of maximizing cell growth. Growth can be defined in terms of biosynthetic requirements based on literature values of biomass composition or experimentally determined values such as those obtained as described above. Thus, biomass generation can be defined as an exchange reaction that removes intermediate metabolites in the appropriate ratios and represented as an objective function. In addition to draining intermediate metabolites this reaction flux can be formed to utilize energy molecules such as ATP, NADH and NADPH so as to incorporate any maintenance requirement that must be met. This new reaction flux then becomes another constraint/balance equation that the system must satisfy as the objective function. Using the stoichiometric matrix of FIG. 3 as an example, adding such a constraint is analogous to adding the additional column Vgrowth to the stoichiometric matrix to represent fluxes to describe the production demands placed on the metabolic system. Setting this new flux as the objective function and asking the system to maximize the value of this flux for a given set of constraints on all the other fluxes is then a method to simulate the growth of the organism.

[0107] Continuing with the example of the stoichiometric matrix applying a constraint set to a reaction network data structure can be illustrated as follows. The solution to equation 5 can be formulated as an optimization problem, in which the flux distribution that minimizes a particular objective is found. Mathematically, this optimization problem can be stated as:

Minimize Z (Eq. 6)

where z=Σci·vi (Eq. 7)

[0108] where Z is the objective which is represented as a linear combination of metabolic fluxes vi using the weights ci in this linear combination. The optimization problem can also be stated as the equivalent maximization problem; i.e. by changing the sign on Z. Any commands for solving the optimazation problem can be used including, for example, linear programming commands.

[0109] A computer system of the invention can further include a user interface capable of receiving a representation of one or more reactions. A user interface of the invention can also be capable of sending at least one command for modifying the data structure, the constraint set or the commands for applying the constraint set to the data representation, or a combination thereof. The interface can be a graphic user interface having graphical means for making selections such as menus or dialog boxes. The interface can be arranged with layered screens accessible by making selections from a main screen. The user interface can provide access to other databases useful in the invention such as a metabolic reaction database or links to other databases having information relevant to the reactions or reactants in the reaction network data structure or to Homo sapiens physiology. Also, the user interface can display a graphical representation of a reaction network or the results of a simulation using a model of the invention.

[0110] Once an initial reaction network data structure and set of constraints has been created, this model can be tested by preliminary simulation. During preliminary simulation, gaps in the network or “dead-ends” in which a metabolite can be produced but not consumed or where a metabolite can be consumed but not produced can be identified. Based on the results of preliminary simulations areas of the metabolic reconstruction that require an additional reaction can be identified. The determination of these gaps can be readily calculated through appropriate queries of the reaction network data structure and need not require the use of simulation strategies, however, simulation would be an alternative approach to locating such gaps.

[0111] In the preliminary simulation testing and model content refinement stage the existing model is subjected to a series of functional tests to determine if it can perform basic requirements such as the ability to produce the required biomass constituents and generate predictions concerning the basic physiological characteristics of the particular cell type being modeled. The more preliminary testing that is conducted the higher the quality of the model that will be generated. Typically, the majority of the simulations used in this stage of development will be single optimizations. A single optimization can be used to calculate a single flux distribution demonstrating how metabolic resources are routed determined from the solution to one optimization problem. An optimization problem can be solved using linear programming as demonstrated in the Examples below. The result can be viewed as a display of a flux distribution on a reaction map. Temporary reactions can be added to the network to determine if they should be included into the model based on modeling/simulation requirements.

[0112] Once a model of the invention is sufficiently complete with respect to the content of the reaction network data structure according to the criteria set forth above, the model can be used to simulate activity of one or more reactions in a reaction network. The results of a simulation can be displayed in a variety of formats including, for example, a table, graph, reaction network, flux distribution map or a phenotypic phase plane graph.

[0113] Thus, the invention provides a method for predicting a Homo sapiens physiological function. The method includes the steps of (a) providing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (b) providing a constraint set for the plurality of Homo sapiens reactions; (c) providing an objective function, and (d) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, thereby predicting a Homo sapiens physiological function.

[0114] A method for predicting a Homo sapiens physiological function can include the steps of (a) providing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product, and wherein at least one of the reactions is a regulated reaction; (b) providing a constraint set for the plurality of reactions, wherein the constraint set includes a variable constraint for the regulated reaction; (c) providing a condition-dependent value to the variable constraint; (d) providing an objective function, and (e) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, thereby predicting a Homo sapiens physiological function.

[0115] As used herein, the term “physiological function,” when used in reference to Homo sapiens, is intended to mean an activity of a Homo sapiens cell as a whole. An activity included in the term can be the magnitude or rate of a change from an initial state of a Homo sapiens cell to a final state of the Homo sapiens cell. An activity included in the term can be, for example, growth, energy production, redox equivalent production, biomass production, development, or consumption of carbon nitrogen, sulfur, phosphate, hydrogen or oxygen. An activity can also be an output of a particular reaction that is determined or predicted in the context of substantially all of the reactions that affect the particular reaction in a Homo sapiens cell or substantially all of the reactions that occur in a Homo sapiens cell (e.g. muscle contraction). Examples of a particular reaction included in the term are production of biomass precursors, production of a protein, production of an amino acid, production of a purine, production of a pyrimidine, production of a lipid, production of a fatty acid, production of a cofactor or transport of a metabolite. A physiological function can include an emergent property which emerges from the whole but not from the sum of parts where the parts are observed in isolation (see for example, Palsson, Nat. Biotech 18:1147-1150 (2000)).

[0116] A physiological function of Homo sapiens reactions can be determined using phase plane analysis of flux distributions. Phase planes are representations of the feasible set which can be presented in two or three dimensions. As an example, two parameters that describe the growth conditions such as substrate and oxygen uptake rates can be defined as two axes of a two-dimensional space. The optimal flux distribution can be calculated from a reaction network data structure and a set of constraints as set forth above for all points in this plane by repeatedly solving the linear programming problem while adjusting the exchange fluxes defining the two-dimensional space. A finite number of qualitatively different metabolic pathway utilization patterns can be identified in such a plane, and lines can be drawn to demarcate these regions. The demarcations defining the regions can be determined using shadow prices of linear optimization as described, for example in Chvatal, Linear Programming New York, W. H. Freeman and Co. (1983). The regions are referred to as regions of constant shadow price structure. The shadow prices define the intrinsic value of each reactant toward the objective function as a number that is either negative, zero, or positive and are graphed according to the uptake rates represented by the x and y axes. When the shadow prices become zero as the value of the uptake rates are changed there is a qualitative shift in the optimal reaction network.

[0117] One demarcation line in the phenotype phase plane is defined as the line of optimality (LO). This line represents the optimal relation between respective metabolic fluxes. The LO can be identified by varying the x-axis flux and calculating the optimal y-axis flux with the objective function defined as the growth flux From the phenotype phase plane analysis the conditions under which a desired activity is optimal can be determined. The maximal uptake rates lead to the definition of a finite area of the plot that is the predicted outcome of a reaction network within the environmental conditions represented by the constraint set. Similar analyses can be performed in multiple dimensions where each dimension on the plot corresponds to a different uptake rate. These and other methods for using phase plane analysis, such as those described in Edwards et al., Biotech Bioeng. 77:27-36(2002), can be used to analyze the results of a simulation using an in silico Homo sapiens model of the invention.

[0118] A physiological function of Homo sapiens can also be determined using a reaction map to display a flux distribution. A reaction map of Homo sapiens can be used to view reaction networks at a variety of levels. In the case of a cellular metabolic reaction network a reaction map can contain the entire reaction complement representing a global perspective. Alternatively, a reaction map can focus on a particular region of metabolism such as a region corresponding to a reaction subsystem described above or even on an individual pathway or reaction.

[0119] Thus, the invention provides an apparatus that produces a representation of a Homo sapiens physiological function, wherein the representation is produced by a process including the steps of: (a) providing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating said substrate and said product; (b) providing a constraint set for the plurality of Homo sapiens reactions; (c) providing an objective function; (d) determining at least one flux distribution that minimizes or maximizes the objective function when the constraint set is applied to the data structure, thereby predicting a Homo sapiens physiological function, and (e) producing a representation of the activity of the one or more Homo sapiens reactions.

[0120] The methods of the invention can be used to determine the activity of a plurality of Homo sapiens reactions including, for example, biosynthesis of an amino acid, degradation of an amino acid, biosynthesis of a purine, biosynthesis of a pyrimidine, biosynthesis of a lipid, metabolism of a fatty acid, biosynthesis of a cofactor, transport of a metabolite and metabolism of an alternative carbon source. In addition, the methods can be used to determine the activity of one or more of the reactions described above or listed in Table 1.

[0121] The methods of the invention can be used to determine a phenotype of a Homo sapiens mutant. The activity of one or more Homo sapiens reactions can be determined using the methods described above, wherein the reaction network data structure lacks one or more gene-associated reactions that occur in Homo sapiens. Alternatively, the methods can be used to determine the activity of one or more Homo sapiens reactions when a reaction that does not naturally occur in Homo sapiens is added to the reaction network data structure. Deletion of a gene can also be represented in a model of the invention by constraining the flux through the reaction to zero, thereby allowing the reaction to remain within the data structure. Thus, simulations can be made to predict the effects of adding or removing genes to or from Homo sapiens. The methods can be particularly useful for determining the effects of adding or deleting a gene that encodes for a gene product that performs a reaction in a peripheral metabolic pathway.

[0122] A drug target or target for any other agent that affects Homo sapiens function can be predicted using the methods of the invention. Such predictions can be made by removing a reaction to simulate total inhibition or prevention by a drug or agent. Alternatively, partial inhibition or reduction in the activity a particular reaction can be predicted by performing the methods with altered constraints. For example, reduced activity can be introduced into a model of the invention by altering the aj or bj values for the metabolic flux vector of a target reaction to reflect a finite maximum or minimum flux value corresponding to the level of inhibition. Similarly, the effects of activating a reaction, by initiating or increasing the activity of the reaction, can be predicted by performing the methods with a reaction network data structure lacking a particular reaction or by altering the aj or bj values for the metabolic flux vector of a target reaction to reflect a maximum or minimum flux value corresponding to the level of activation. The methods can be particularly useful for identifying a target in a peripheral metabolic pathway.

[0123] Once a reaction has been identified for which activation or inhibition produces a desired effect on Homo sapiens function, an enzyme or macromolecule that performs the reaction in Homo sapiens or a gene that expresses the enzyme or macromolecule can be identified as a target for a drug or other agent. A candidate compound for a target identified by the methods of the invention can be isolated or synthesized using known methods. Such methods for isolating or synthesizing compounds can include, for example, rational design based on known properties of the target (see, for example, DeCamp et al., Protein Engineering Principles and Practice, Ed. Cleland and Craik, Wiley-Liss, New York, pp. 467-506 (1996)), screening the target against combinatorial libraries of compounds (see for example, Houghten et al., Nature, 354, 84-86 (1991); Dooley et al., Science, 266, 2019-2022 (1994), which describe an iterative approach, or R. Houghten et al. PCT/US91/08694 and U.S. Pat. No. 5,556,762 which describe the positional-scanning approach), or a combination of both to obtain focused libraries. Those skilled in the art will know or will be able to routinely determine assay conditions to be used in a screen based on properties of the target or activity assays known in the art.

[0124] A candidate drug or agent, whether identified by the methods described above or by other methods known in the art, can be validated using an in silico Homo sapiens model or method of the invention. The effect of a candidate drug or agent on Homo sapiens physiological function can be predicted based on the activity for a target in the presence of the candidate drug or agent measured in vitro or in vivo. This activity can be represented in an in silico Homo sapiens model by adding a reaction to the model, removing a reaction from the model or adjusting a constraint for a reaction in the model to reflect the measured effect of the candidate drug or agent on the activity of the reaction. By running a simulation under these conditions the holistic effect of the candidate drug or agent on Homo sapiens physiological function can be predicted.

[0125] The methods of the invention can be used to determine the effects of one or more environmental components or conditions on an activity of a Homo sapiens cell. As set forth above an exchange reaction can be added to a reaction network data structure corresponding to uptake of an environmental component, release of a component to the environment, or other environmental demand. The effect of the environmental component or condition can be further investigated by running simulations with adjusted aj or bj values for the metabolic flux vector of the exchange reaction target reaction to reflect a finite maximum or minimum flux value corresponding to the effect of the environmental component or condition. The environmental component can be, for example an alternative carbon source or a metabolite that when added to the environment of a Homo sapiens cell can be taken up and metabolized. The environmental component can also be a combination of components present for example in a minimal medium composition. Thus, the methods can be used to determine an optimal or minimal medium composition that is capable of supporting a particular activity of Homo sapiens.

[0126] The invention further provides a method for determining a set of environmental components to achieve a desired activity for Homo sapiens. The method includes the steps of (a) providing a data structure relating a plurality of Homo sapiens reactants to a plurality of Homo sapiens reactions, wherein each of the Homo sapiens reactions includes a reactant identified as a substrate of the reaction, a reactant identified as a product of the reaction and a stoichiometric coefficient relating the substrate and the product; (b)providing a constraint set for the plurality of Homo sapiens reactions; (c) applying the constraint set to the data representation, thereby determining the activity of one or more Homo sapiens reactions (d) determining the activity of one or more Homo sapiens reactions according to steps (a) through (c), wherein the constraint set includes an upper or lower bound on the amount of an environmental component and (e) repeating steps (a) through (c) with a changed constraint set, wherein the activity determined in step (e) is improved compared to the activity determined in step (d).

[0127] The following examples are intended to illustrate but not limit the present invention.

EXAMPLE I

[0128] This example shows the construction of a universal Homo sapiens metabolic reaction database, a Homo sapiens core metabolic reaction database and a Homo sapiens muscle cell metabolic reaction database. This example also shows the iterative model building process used to generate a Homo sapiens core metabolic model and a Homo sapiens muscle cell metabolic model.

[0129] A universal Homo sapiens reaction database was prepared from the genome databases and biochemical literature. The reaction database shown in Table 1 contains the following information:

[0130] Locus ID—the locus number of the gene found in the LocusLink website.

[0131] Gene Ab.—various abbreviations which are used for the gene.

[0132] Reaction Stoichiometry—includes all metabolites and direction of the reaction, as well as reversibility.

[0133] E.C.—The Enzyme Commission number.

[0134] Additional information included in the universal reaction database, although not shown in Table 1, included the chapter of Salway, supra (1999), where relevant reactions were found; the cellular location, if the reaction primarily occurs in a given compartment; the SWISS PROT identifier, which can be used to locate the gene record in SWISS PROT; the full name of the gene at the given locus; the chromosomal location of the gene; the Mendelian Inheritance in Man (MIM) data associated with the gene; and the tissue type, if the gene is primarily expressed in a certain tissue. Overall, 1130 metabolic enzyme- or transporter-encoding genes were included in the universal reaction database.

[0135] Fifty-nine reactions in the universal reaction database were identified and included based on biological data as found in Salway supra (1999), currently without genome annotation. Ten additional reactions, not described in the biochemical literature or genome annotation, were subsequently included in the reaction database following preliminary simulation testing and model content refinement. These 69 reactions are shown at the end of Table 1.

[0136] From the universal Homo sapiens reaction database shown in Table 1, a core metabolic reaction database was established, which included core metabolic reactions as well as some amino acid and fatty acid metabolic reactions, as described in Chapters 1, 3, 4, 7, 9, 10, 13, 17, 18 and 44 of J. G. Salway, Metabolism at a Glance, 2nd ed., Blackwell Science, Malden, Mass. (1999). The core metabolic reaction database included 211 unique reactions, accounting for 737 genes in the Homo sapiens genome. The core metabolic reaction database was used, although not in its entirety, to create the core metabolic model described in Example II.

[0137] To allow for the modeling of muscle cells, the core reaction database was expanded to include 446 unique reactions, accounting for 889 genes in the Homo sapiens genome. This skeletal muscle metabolic reaction database was used to create the skeletal muscle metabolic model described in Example II.

[0138] Once the core and muscle cell metabolic reaction databases were compiled, the reactions were represented as a metabolic network data structure, or “stoichiometric input file.” For example, the core metabolic network data structure shown in Table 2 contains 33 reversible reactions, 31 non-reversible reactions, 97 matrix columns and 52 unique enzymes. Each reaction in Table 2 is represented so as to indicate the substrate or substrates (a negative number) and the product or products (a positive number); the stoichiometry; the name of each reaction (the term following the zero); and whether the reaction is reversible (an R following the reaction name). A metabolite that appears in the mitochondria is indicated by an “m,” and a metabolite that appears in the extracellular space is indicated by an “ex.”

[0139] To perform a preliminary simulation or to simulate a physiological condition, a set of inputs and outputs has to be defined and the network objective function specified. To calculate the maximum ATP production of the Homo sapiens core metabolic network using glucose as a carbon source, a non-zero uptake value for glucose was assigned and ATP production was maximized as the objective function, using the representation shown in Table 2. The network's performance was examined by optimizing for the given objective function and the set of constraints defined in the input file, using flux balance analysis methods. The model was refined in an iterative manner by examining the results of the simulation and implementing the appropriate changes.

[0140] Using this iterative procedure, two metabolic reaction networks were generated, representing human core metabolism and human skeletal muscle cell metabolism.

EXAMPLE II

[0141] This example shows how human metabolism can be accurately simulated using a Homo sapiens core metabolic model.

[0142] The human core metabolic reaction database shown in Table 3 was used in simulations of human core metabolism. This reaction database contains a total of 65 reactions, covering the classic biochemical pathways of glycolysis, the pentose phosphate pathway, the tricitric acid cycle, oxidative phosphorylation, glycogen storage, the malate/aspartate shuttle, the glycerol phosphate shuttle, and plasma and mitochondrial membrane transporters. The reaction network was divided into three compartments: the cytosol, mitochondria, and the extracellular space. The total number of metabolites in the network is 50, of which 35 also appear in the mitochondria. This core metabolic network accounts for 250 human genes.

[0143] To perform simulations using the core metabolic network, network properties such as the P/O ratio were specified using Salway, supra (1999) as a reference. Oxidation of NADH through the Electron Transport System (ETS) was set to generate 2.5 ATP molecules (i.e. a P/O ratio of 2.5 for NADH), and that of FADH2 was set to 1.5 ATP molecules (i.e. a P/O ratio of 1.5 for FADH2).

[0144] Using the core metabolic network, aerobic and anaerobic metabolisms were simulated in silico. Secretion-of metabolic by-products was in agreement with the known physiological parameters. Maximum yield of all 12 precursor-metabolites (glucose-6-phosphate, fructose-6-phosphate, ribose-5-phosphate, erythrose-4-phosphate, triose phosphate, 3-phosphoglycerate, phosphoenolpyruvate, pyruvate, acetyl CoA, α-ketoglutarate, succinyl CoA, and oxaloacetate) was examined and none found to exceed the values of its theoretical yield.

[0145] Maximum ATP yield was also examined in the cytosol and mitochondria. Salway, supra (1999) reports that in the absence of membrane proton-coupled transport systems, the energy yield is 38 ATP molecules per molecule of glucose and otherwise 31 ATP molecules per molecule of glucose. The core metabolic model demonstrated the same values as described by Salway supra (1999). Energy yield in the mitochondria was determined to be 38 molecules of ATP per glucose molecule. This is equivalent to production of energy in the absence of proton-couple transporters across mitochondrial membrane since all the protons were utilized only in oxidative phosphorylation. In the cytosol, energy yield was calculated to be 30.5 molecules of ATP per glucose molecule. This value reflects the cost of metabolite exchange across the mitochondrial membrane as described by Salway, supra (1999).

EXAMPLE III

[0146] This example shows how human muscle cell metabolism can be accurately simulated under various physiological and pathological conditions using a Homo sapiens muscle cell metabolic model.

[0147] As described in Example I, the core metabolic model was extended to also include all the major reactions occurring in the skeletal muscle cell, adding new functions to the classical metabolic pathways found in the core model, such as fatty acid synthesis and β-oxidation, triacylglycerol and phospholipid formation, and amino acid metabolism. Simulations were performed using the muscle cell reaction database shown in Table 4. The biochemical reactions were again compartmentalized into cytosolic and mitochondrial compartments.

[0148] To simulate physiological behavior of human skeletal muscle cells, an objective function had to be defined. Growth of muscle cells occurs in time scales of several hours to days. The time scale of interest in the simulation, however, was in the order of several to tens of minutes, reflecting the time period of metabolic changes during exercise. Thus, contraction (defined as, and related to energy production) was chosen to be the objective function, and no additional constraints were imposed to represent growth demands in the cell.

[0149] To study and test the behavior of the network, twelve physiological cases (Table 5) and five disease cases (Table 6) were examined. The input and output of metabolites were specified as indicated in Table 5, and maximum energy production and metabolite secretions were calculated and taken into account.

1TABLE 5MetaboliteExchange123456789101112GlucoseII——II——————O2I—I—I—I—I—I—PalmitateII——————II——GlycogenIIII————————Phosphocrea-II————————IItineTriacylgly-II————II————cerolIsoleucineII——————————ValineII——————————Hydroxybuty-————————————ratePyruvateOOOOOOOOOOOOLactateOOOOOOOOOOOOAlbuminOOOOOOOOOOOO

[0150]

2

TABLE 6

Reaction

Disease
Enzyme Deficiency
Constrained

McArdle's disease
phosphorylase
GBE1

Tarui's disease
phosphofructokianse
PFKL

Phosphoglycerate
phosphoglycerate kinase
PGK1R

kinase deficiency

Phosphoglycerate
phosphoglycerate mutase
PGAM3R

mutase deficiency

Lactate dehydrogenase
Lactate dehyrogenase
LDHAR

deficiency

[0151] The skeletal muscle model was tested for utilization of various carbon sources available during various stages of exercise and food starvation (Table 5). The by-product secretion of the network in an aerobic to anaerobic shift was qualitatively compared to physiological outcome of exercise and found to exhibit the same general features such as secretion of fermentative by-products and lowered energy yield.

[0152] The network behavior was also examined for five disease cases (Table 6). The test cases were chosen based on their physiological relevance to the model's predictive capabilities. In brief, McArdle's disease is marked by the impairment of glycogen breakdown. Tarui's disease is characterized by a deficiency in phosphofructokinase. The remaining diseases examined are marked by a deficiency of metabolic enzymes phosphoglycerate kinase, phosphoglycerate mutase, and lactate dehydrogenase. In each case, the changes in flux and by-product secretion of metabolites were examined for an aerobic to anaerobic metabolic shift with glycogen and phosphocreatine as the sole carbon sources to the network and pyruvate, lactate, and albumin as the only metabolic by-products allowed to leave the system. To simulate the disease cases, the corresponding deficient enzyme was constrained to zero. In all cases, a severe reduction in energy production was demonstrated during exercise, representing the state of the disease as seen in clinical cases.

[0153] Throughout this application various publications have been referenced. The disclosures of these publications in their entireties are hereby incorporated by reference in this application in order to more fully describe the state of the art to which this invention pertains.

[0154] Although the invention has been described with reference to the examples provided above, it should be understood that various modifications can be made without departing from the spirit of the invention. Accordingly, the invention is limited only by the claims.

3TABLE 1Locus IDGene Ab.Reaction StoichiometryE.C.1. Carbohydrate Metabolism1.1 Glycolysis/Gluconeogenesis [PATH: hsa00010]3098HK1GLC + ATP -> G6P + ADP2.7.1.13099HK2GLC + ATP -> G6P + ADP2.7.1.13101HK3GLC + ATP -> G6P + ADP2.7.1.12645GCK, HK4, MODY2, NIDDMGLC + ATP -> G6P + ADP2.7.1.22538G6PC, G6PTG6P + H2O -> GLC + PI3.1.3.92821GPIG6P <-> F6P5.3.1.95211PFKLF6P + ATP -> FDP + ADP2.7.1.115213PFKMF6P + ATP -> FDP + ADP2.7.1.115214PFKP, PFK-CF6P + ATP -> FDP + ADP2.7.1.115215PFKXF6P + ATP -> FDP + ADP2.7.1.112203FBP1, FBPFDP + H2O -> F6P + PI3.1.3.118789FBP2FDP + H2O -> F6P + PI3.1.3.11226ALDOAFDP <-> T3P2 + T3P14.1.2.13229ALDOBFDP <-> T3P2 + T3P14.1.2.13230ALDOCFDP <-> T3P2 + T3P14.1.2.137167TPI1T3P2 <-> T3P15.3.1.12597GAPD, GAPDHT3P1 + PI + NAD <-> NADH + 13PDG1.2.1.1226300GAPDS, GAPDH-2T3P1 + PI + NAD <-> NADH + 13PDG1.2.1.125230PGK1, PGKA13PDG + ADP <-> 3PG + ATP2.7.2.35233PGK213PDG + ADP <-> 3PG + ATP2.7.2.35223PGAM1, PGAMA13PDG -> 23PDG5.4.2.423PDG + H2O -> 3PG + PI3.1.3.133PG <-> 2PG5.4.2.15224PGAM2, PGAMM13PDG <-> 23PDG5.4.2.423PDG + H2O -> 3PG + PI3.1.3.133PG <-> 2PG5.4.2.1669BPGM13PDG <-> 23PDG5.4.2.423PDG + H2O <-> 3PG + PI3.1.3.1.33PG <-> 2PG5.4.2.12023ENO1, PPH, ENO1L12PG <-> PEP + H2O4.2.1.112026ENO22PG <-> PEP + H2O4.2.1.112027ENO32PG <-> PEP + H2O4.2.1.1126237ENO1B2PG <-> PEP + H2O4.2.1.115313PKLR, PK1PEP + ADP -> PYR + ATP2.7.1.405315PKM2, PK3, THBP1, OIP3PEP + ADP -> PYR + ATP2.7.1.405160PDHA1, PHE1A, PDHAPYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm1.2.4.15161PDHA2, PDHALPYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm1.2.4.15162PDHBPYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm1.2.4.11737DLAT, DLTA, PDC-E2PYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm2.3.1.128050PDX1, E3BPPYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm2.3.1.123939LDHA, LDH1NAD + LAC <-> PYR + NADH1.1.1.273945LDHBNAD + LAC <-> PYR + NADH1.1.1.273948LDHC, LDH3NAD + LAC <-> PYR + NADH1.1.1.275236PGM1G1P <-> G6P5.4.2.25237PGM2G1P <-> G6P5.4.2.25238PGM3G1P <-> G6P5.4.2.21738DLD, LAD, PHE3, DLDH, E3DLIPOm + FADm <-> LIPOm + FADH2m1.8.1.4124ADH1ETH + NAD <-> ACAL + NADH1.1.1.1125ADH2ETH + NAD <-> ACAL + NADH1.1.1.1126ADH3ETH + NAD <-> ACAL + NADH1.1.1.1127ADH4ETH + NAD <-> ACAL + NADH1.1.1.1128ADH5FALD + RGT + NAD <-> FGT + NADH1.2.1.1ETH + NAD <-> ACAL + NADH1.1.1.1130ADH6ETH + NAD <-> ACAL + NADH1.1.1.1131ADH7ETH + NAD <-> ACAL + NADH1.1.1.110327AKR1A1, ALR, ALDR11.1.1.297ACYP13.6.1.798ACYP23.6.1.71.2 Citrate cycle (TCA cycle) PATH: hsa000201431CSACCOAm + OAm + H2Om -> COAm + CITm4.1.3.748ACO1, IREB1, IRP1CIT <-> ICIT4.2.1.350ACO2CITm <-> ICITm4.2.1.33417IDH1ICIT + NADP -> NADPH + CO2 + AKG1.1.1.423418IDH2ICITm + NADPm -> NADPHm + CO2m + AKGm1.1.1.423419IDH3AICITm + NADm -> CO2m + NADHm + AKGm1.1.1.413420IDH3BICITm + NADm -> CO2m + NADHm + AKGm1.1.1.413421IDH3GICITm + NADm -> CO2m + NADHm + AKGm1.1.1.414967OGDHAKGm + NADm + COAm -> CO2m + NADHm + SUCCOAm1.2.4.21743DLST, DLTSAKGm + NADm + COAm -> CO2m + NADHm + SUCCOAm2.3.1.618802SUCLG1, SUCLA1GTPm + SUCCm + COAm <-> GDPm + PIm + SUCCOAm6.2.1.48803SUCLA2ATPm + SUCCm + COAm <-> ADPm + PIm + SUCCOAm6.2.1.42271FHFUMm + H2Om <-> MALm4.2.1.24190MDH1MAL + NAD <-> NADH + OA1.1.1.374191MDH2MALm + NADm <-> NADHm + OAm1.1.1.375091PC, PCBPYRm + ATPm + CO2m -> ADPm + OAm + PIm6.4.1.147ACLY, ATPCL, CLATPATP + CIT + COA + H2O -> ADP + PI + ACCOA + OA4.1.3.836575105PCK1OA + GTP -> PEP + GDP + CO24.1.1.325106PCK2, PEPCKOAm + GTPm -> PEPm + GDPm + CO2m4.1.1.321.3 Pentose phosphate cycle PATH: hsa000302539G6PD, G6PD1G6P + NADP <-> D6PGL + NADPH1.1.1.499563H6PD1.1.1.47D6PGL + H2O -> D6PGC3.1.1.3125796PGLS, 6PGLD6PGL + H2O -> D6PGC3.1.1.315226PGDD6PGC + NADP -> NADPH + CO2 + RL5P1.1.1.446120RPERL5P <-> X5P5.1.3.17086TKTR5P + X5P <-> T3P1 + S7P2.2.1.1X5P + E4P <-> F6P + T3P18277TKTL1, TKR, TKT2R5P + X5P <-> T3P1 + S7P2.2.1.1X5P + E4P <-> F6P + T3P16888TALDO1T3P1 + S7P <-> E4P + F6P2.2.1.25631PRPS1, PRS I, PRS, IR5P + ATP <-> PRPP + AMP2.7.6.15634PRPS2, PRS II, PRS, IIR5P + ATP <-> PRPP + AMP2.7.6.12663GDH1.1.1.471.4 Pentose and glucuronate interconversions PATH: hsa00040231AKR1B1, AR, ALDR1, ADR1.1.1.217359UGP1G1P + UTP -> UDPG + PPI2.7.7.97360UGP2, UGPP2G1P + UTP -> UDPG + PPI2.7.7.97358UGDH, UDPGDH1.1.1.2210720UGT2B112.4.1.1754658UGT1A1, UGT1A, GNT1, UGT12.4.1.177361UGT1A, UGT1, UGT1A2.4.1.177362UGT2B, UGT2, UGT2B2.4.1.177363UGT2B4, UGT2B112.4.1.177364UGT2B7, UGT2B92.4.1.177365UGT2B102.4.1.177366UGT2B15, UGT2B82.4.1.177367UGT2B172.4.1.1713AADAC, DAC3.1.1.—3991LIPE, LHS, HSL3.1.1.—1.5 Fructose and mannose metabolism PATH: hsa000514351MPI, PMI1MAN6P <-> F6P5.3.1.85372PMM1MAN6P <-> MAN1P5.4.2.85373PMM2, CDG1, CDGSMAN6P <-> MAN1P5.4.2.82762GMDS4.2.1.478790FPGT, GFPP2.7.7.305207PFKFB1, PFRXATP + F6P -> ADP + F26P2.7.1.105F26P -> F6P + PI3.1.3.465208PFKFB2ATP + F6P -> ADP + F26P2.7.1.105F26P -> F6P + PI3.1.3.465209PFKFB3ATP + F6P -> ADP + F26P2.7.1.105F26P -> F6P + PI3.1.3.465210PFKFB4ATP + F6P -> ADP + F26P2.7.1.105F26P -> F6P + PI3.1.3.463795KHK2.7.1.36652SORDDSOT + NAD -> FRU + NADH1.1.1.142526FUT4, FCT3A, FUC-TIV2.4.1.—2529FUT72.4.1.—3036HAS1, HAS2.4.1.—3037HAS22.4.1.—8473OGT, O-GLCNAC2.4.1.—51144LOC511441.1.1.—1.6 Galactose metabolism PATH: hsa000522584GALK1, GALKGLAC + ATP -> GAL1P + ADP2.7.1.62585GALK2, GK2GLAC + ATP -> GAL1P + ADP2.7.1.62592GALTUTP + GAL1P <-> PPI + UDPGAL2.7.7.102582GALEUDPGAL <-> UDPG5.1.3.22720GLB13.2.1.233938LCT, LAC3.2.1.623.2.1.1082683B4GALT1, GGTB2, BETA4GAL-T1,2.4.1.90GT1, GTB2.4.1.382.4.1.223906LALBA2.4.1.222717GLA, GALAMELI -> GLC + GLAC3.2.1.222548GAAMLT -> 2 GLC3.2.1.206DGLC -> GLAC + GLC2594GANABMLT -> 2 GLC3.2.1.206DGLC -> GLAC + GLC2595GANCMLT -> 2 GLC3.2.1.206DGLC -> GLAC + GLC8972MGAM, MG, MGAMLT -> 2 GLC3.2.1.206DGLC -> GLAC + GLC3.2.1.31.7 Ascorbate and aldarate metabolism PATH: hsa00053216ALDH1, PUMB1ACAL + NAD -> NADH + AC1.2.1.3217ALDH2ACALm + NADm -> NADHm + ACm1.2.1.3219ALDH5, ALDHX1.2.1.3223ALDH9, E31.2.1.31.2.1.19224ALDH10, FALDH, SLS1.2.1.38854RALDH21.2.1.31591CYP241.14.—.—1592CYP26A1, P450RAI1.14.—.—1593CYP27A1, CTX, CYP271.14.—.—1594CYP27B1, PDDR, VDD1, VDR, CYP1,1.14.—.—VDDR, I, P450C11.8 Pyruvate metabolism PATH: hsa0062054988FLJ20581ATP + AC + COA -> AMP + PPI + ACCOA6.2.1.131ACACA, ACAC, ACCACCOA + ATP + CO2 <-> MALCOA + ADP + PI + H6.4.1.26.3.4.1432ACACB, ACCB, HACC275, ACC2ACCOA + ATP + CO2 <-> MALCOA + ADP + PI + H6.4.1.26.3.4.142739GLO1, GLYIRGT + MTHGXL <-> LGT4.4.1.53029HAGH, GLO2LGT -> RGT + LAC3.1.2.62223FDHFALD + RGT + NAD <-> FGT + NADH1.2.1.19380GRHPR, GLXR1.1.1.794200ME2MALm + NADm -> CO2m + NADHm + PYRm1.1.1.3810873ME3MALm + NADPm -> CO2m + NADPHm + PYRm1.1.1.4029897HUMNDMEMAL + NADP -> CO2 + NADPH + PYR1.1.1.404199ME1MAL + NADP -> CO2 + NADPH + PYR1.1.1.4038ACAT1, ACAT, T2, THIL, MAT2 ACCOAm <-> COAm + AACCOAm2.3.1.939ACAT22 ACCOAm <-> COAm + AACCOAm2.3.1.91.9 Glyoxylate and dicarboxylate metabolism PATH: hsa006305240PGP3.1.3.182758GLYD3HPm + NADHm -> NADm + GLYAm1.1.1.2910797MTHFD2, NMDMCMETHF <-> FTHF3.5.4.9METTHF + NAD -> METHF + NADH1.5.1.154522MTHFD1METTHF + NADP <-> METHF + NADPH1.5.1.15METHF <-> FTHF3.5.4.9THF + FOR + ATP -> ADP + PI + FTHF6.3.4.31.10 Propanoate metabolism PATH: hsa0064034ACADM, MCADMBCOAm + FADm -> MCCOAm + FADH2m1.3.99.3IBCOAm + FADm -> MACOAm + FADH2mIVCOAm + FADm -> MCRCOAm + FADH2m36ACADSBMBCOAm + FADm -> MCCOAm + FADH2m1.3.99.3IBCOAm + FADm -> MACOAm + FADH2mIVCOAm + FADm -> MCRCOAm + FADH2m1892ECHS1, SCEHMACOAm + H2Om -> HIBCOAm4.2.1.17MCCOAm + H2Om -> MHVCOAm1962EHHADHMHVCOAm + NADm -> MAACOAm + NADHm1.1.1.35HIBm + NADm -> MMAm + NADHmMACOAm + H2Om -> HIBCOAm4.2.1.17MCCOAm + H2Om -> MHVCOAm3030HADHA, MTPA, GBPMHVCOAm + NADm -> MAACOAm + NADHm1.1.1.35HIBm + NADm -> MMAm + NADHmMACOAm + H2Om -> HIBCOAm4.2.1.17MCCOAm + H2Om -> MHVCOAmC16CARm + COAm + FADm + NADm -> FADH2m +1.1.1.35NADHm + C140COAm + ACCOAm4.2.1.1723417MLYCD, MCD4.1.1.1918ABAT, GABATGABA + AKG -> SUCCSAL + GLU2.6.1.195095PCCAPROPCOAm + CO2m + ATPm -> ADPm + PIm + DMMCOAm6.4.1.35096PCCBPROPCOAm + CO2m + ATPm -> ADPm + PIm + DMMCOAm6.4.1.34594MUT, MCMLMMCOAm -> SUCCOAm5.4.99.24329MMSDHMMAm + COAm + NADm -> NADHm + CO2m + PROPCOAm1.2.1.278523FACVL1, VLCS, VLACS6.2.1.—1.11 Butanoate metabolism PATH: hsa006503028HADH2, ERABC140COAm + 7 COAm + 7 FADm + 7 NADm -> 7 FADH2m + 71.1.1.35NADHm + 7 ACCOAm3033HADHSC, SCHAD1.1.1.3535ACADS, SCADMBCOAm + FADm -> MCCOAm + FADH2m1.3.99.2IBCOAm + FADm -> MACOAm + FADH2m7915ALDH5A1, SSADH, SSDH1.2.1.242571GAD1, GAD, GAD67, GAD25GLU -> GABA + CO24.1.1.152572GAD2GLU -> GABA + CO24.1.1.152573GAD3GLU -> GABA + CO24.1.1.153157HMGCS1, HMGCSH3MCOA + COA <-> ACCOA + AACCOA4.1.3.53158HMGCS2H3MCOA + COA <-> ACCOA + AACCOA4.1.3.53155HMGCL, HLH3MCOAm -> ACCOAm + ACTACm4.1.3.45019OXCT2.8.3.5622BDH3HBm + NADm -> NADHm + Hm + ACTACm1.1.1.301629DBT, BCATE2OMVALm + COAm + NADm -> MBCOAm + NADHm + CO2m2.3.1.—OIVALm + COAm + NADm -> IBCOAm + NADHm + CO2mOICAPm + COAm + NADHm -> IVCOAm + NADHm + CO2m1.13 Inositol metabolism PATH: hsa000312. Energy Metabolism2.1 Oxidative phosphorylation PATH: hsa001904535MTND1NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34536MTND2NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34537MTND3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34538MTND4NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34539MTND4LNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34540MTND5NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34541MTND6NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34694NDUFA1, MWFENADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34695NDUFA2, B8NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34696NDUFA3, B9NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34697NDUFA4, MLRQNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34698NDUFA5, UQOR13, B13NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34700NDUFA6, B14NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34701NDUFA7, B14.5a, B14.5ANADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34702NDUFA8, PGIVNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34704NDUFA9, NDUFS2LNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34705NDUFA10NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34706NDUFAB1, SDAPNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34707NDUFB1, MNLL, CI-SGDHNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34708NDUFB2, AGGGNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34709NDUFB3, B12NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34710NDUFB4, B15NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34711NDUFB5, SGDHNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34712NDUFB6, B17NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34713NDUFB7, B18NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34714NDUFB8, ASHINADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34715NDUFB9, UQOR22, B22NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34716NDUFB10, PDSWNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34717NDUFC1, KFYINADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34718NDUFC2, B14.5b, B14.5BNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34724NDUFS4, AQDQNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34725NDUFS5NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34726NDUFS6NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34731NDUFV3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34727NDUFS7, PSSTNADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34722NDUFS3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34720NDUFS2NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34729NDUFV2NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34723NDUFV1, UQOR1NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.34719NDUFS1, PRO1304NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.34728NDUFS8NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.5.3NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H1.6.99.36391SDHCSUCCm + FADm <-> FUMm + FADH2m1.3.5.1FADH2m + Qm <-> FADm + QH2m6392SDHD, CBT1, PGL, PGL1SUCCm + FADm <-> FUMm + FADH2m1.3.5.1FADH2m + Qm <-> FADm + QH2m6389SDHA, SDH2, SDHF, FPSUCCm + FADm <-> FUMm + FADH2m1.3.5.1FADH2m + Qm <-> FADm + QH2m6390SDHB, SDH1, IP, SDHSUCCm + FADm <-> FUMm + FADH2m1.3.5.1FADH2m + Qm <-> FADm + QH2m7386UQCRFS1, RIS1O2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.24519MTCYBO2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.21537CYC1O2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.27384UQCRC1, D3S3191O2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.27385UQCRC2O2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.27388UQCRHO2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.27381UQCRB, QPC, UQBP, QP-CO2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.227089QP-CO2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.210975UQCRO2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H1.10.2.21333COX5BL4QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.14514MTCO3QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.14512MTCO1QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.14513MTCO2QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11329COX5BQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11327COX4QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11337COX6A1, COX6AQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11339COX6A2QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11340COX6BQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11345COX6CQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.19377COX5A, COX, VA, COX-VAQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11346COX7A1, COX7AM, COX7AQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11347COX7A2, COX VIIa-LQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11348COX7A3QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11349COX7BQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.19167COX7A2L, COX7RP, EB1QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11350COX7CQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.11351COX8, COX VIIIQH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H1.9.3.14508MTATP6ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.344509MTATP8ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34499ATP5A2ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34507ATP5BL1, ATPSBL1ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34508ATP5BL2, ATPSBL2ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34519ATP5HADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34537ATP6S1, ORF, VATPS1, XAP-3ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34514ATP5EADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34513ATP5DADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34506ATP5B, ATPSBADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34509ATP5C1, ATP5CADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34498ATP5A1, ATP5A, ATPM, OMR, HATP1ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34539ATP5O, ATPO, OSCPADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34516ATP5G1, ATP5GADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34517ATP5G2ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34518ATP5G3ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34515ATP5F1ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34521ATP5IADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34522ATP5J, ATP5A, ATPM, ATP5ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.349551ATP5J2, ATP5JL, F1FO-ATPASEADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.3410476ATP5JDADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.3410632ATP5JGADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.349296ATP6S14ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34528ATP6DADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34523ATP6A1, VPP2ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34524ATP6A2, VPP2ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34525ATP6B1, VPP3, VATBADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34526ATP6B2, VPP3ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34529ATP6EADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34527ATP6C, ATPLADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34533ATP6FADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.3410312TCIRG1, TIRC7, OC-116, OC-116kDa,ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34OC-116KDA, ATP6N1C23545TJ6ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.3450617ATP6N1BADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34535ATP6N1ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.3451382VATDADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.348992ATP6HADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.349550ATP6JADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.3451606LOC51606ADPm + Pim + 3 H -> ATPm + 3 Hm + H2Om3.6.1.34495ATP4A, ATP6AATP + H + Kxt + H2O <-> ADP + PI + Hext + K3.6.1.36496ATP4B, ATP6BATP + H + Kxt + H2O <-> ADP + PI + Hext + K3.6.1.36476ATP1A1ATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.37477ATP1A2ATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.37478ATP1A3ATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.37479ATP1AL1ATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.3723439ATP1B4ATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.37481ATP1B1, ATP1BATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.37482ATP1B2, AMOGATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.37483ATP1B3ATP + 3 NA + 2 Kxt + H2O <-> ADP + 3 NAxt + 2 K + PI3.6.1.3727032ATP2C1, ATP2C1A, PMR1ATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38487ATP2A1, SERCA1, ATP2AATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38488ATP2A2, ATP2B, SERCA2, DAR, DDATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38489ATP2A3, SERCA3ATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38490ATP2B1, PMCA1ATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38491ATP2B2, PMCA2ATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38492ATP2B3, PMCA3ATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38493ATP2B4, ATP2B2, PMCA4ATP + 2 CA + H2O <-> ADP + PI + 2 CAxt3.6.1.38538ATP7A, MK, MNK, OHSATP + H2O + Cu2 -> ADP + PI + Cu2xt3.6.3.4540ATP7B, WNDATP + H20 + Cu2 -> ADP + PI + Cu2xt3.6.3.45464PP, SID6-8061PPI -> 2 PI3.6.1.12.2 Photosynthesis PATH: hsa001952.3 Carbon fixation PATH: hsa007102805GOT1OAm + GLUm <-> ASPm + AKGm2.6.1.12806GOT2OA + GLU <-> ASP + AKG2.6.1.12875GPTPYR + GLU <-> AKG + ALA2.6.1.22.4 Reductive carboxylate cycle (CO2 fixation) PATH: hsa007202.5 Methane metabolism PATH: hsa00680847CAT2H2O2 -> O21.11.1.64025LPO, SPO1.11.1.74353MPO1.11.1.78288EPX, EPX-PEN, EPO, EPP1.11.1.79588KIAA0106, AOP21.11.1.76470SHMT1, CSHMTTHF + SER <-> GLY + METTHF2.1.2.16472SHMT2, GLYA, SHMTTHFm + SERm <-> GLYm + METTHFm2.1.2.151004LOC510042OPMPm + O2m -> 2OPMBm1.14.13.—2OPMMBm + O2m -> 2OMHMBm9420CYP7B12OPMPm + O2m -> 2OPMBm1.14.13.—2OPMMBm + O2m -> 2OMHMBm2.6 Nitrogen metabolism PATH: hsa0091011238CA5B4.2.1.123632CA144.2.1.1759CA14.2.1.1760CA24.2.1.1761CA3, CAIII4.2.1.1762CA4, CAIV4.2.1.1763CA5A, CA5, CAV, CAVA4.2.1.1765CA64.2.1.1766CA74.2.1.1767CA8, CALS, CARP4.2.1.1768CA9, MN4.2.1.1770CA11, CARP24.2.1.1771CA124.2.1.11373CPS1GLUm + CO2m + 2 ATPm -> 2 ADPm + 2 PIm + CAPm6.3.4.16275AMTGLYm + THFm + NADm <-> METTHFm + NADHm + CO2m +2.1.2.10NH3m3034HAL, HSTD, HISHIS -> NH3 + URO4.3.1.32746GLUD1, GLUDAKGm + NADHm + NH3m <-> NADm + H2Om + GLUm1.4.1.3AKGm + NADPHm + NH3m <-> NADPm + H2Om + GLUm8307GLUD2AKGm + NADHm + NH3m <-> NADm + H2Om + GLUm1.4.1.3AKGm + NADPHm + NH3m <-> NADPm + H2Om + GLUm2752GLUL, GLNSGLUm + NH3m + ATPm -> GLNm + ADPm + Pim6.3.1.222842KIAA0838GLN -> GLU + NH33.5.1.227165GAGLN -> GLU + NH33.5.1.22744GLSGLNm -> GLUm + NH3m3.5.1.2440ASNSASPm + ATPm + GLNm -> GLUm + ASNm + AMPm + PPIm6.3.5.41491CTHLLCT + H2O -> CYS + HSER4.4.1.1OBUT + NH3 <-> HSER4.4.1.12.7 Sulfur metabolism PATH: hsa009209060PAPSS2, ATPSK2, SK2APS + ATP -> ADP + PAPS2.7.1.25SLF + ATP -> PPI + APS2.7.7.49061PAPSS1, ATPSK1, SK1APS + ATP -> ADP + PAPS2.7.1.25SLF + ATP -> PPI + APS2.7.7.410380BPNT1PAP -> AMP + PI3.1.3.76799SULT1A22.8.2.16817SULT1A1, STP12.8.2.16818SULT1A3, STM2.8.2.1.6822SULT2A1, STD2.8.2.26783STE, EST2.8.2.46821SUOX1.8.3.13. Lipid Metabolism3.1 Fatty acid biosynthesis (path 1) PATH: hsa000612194FASN2.3.1.853.2 Fatty acid biosynthesis (path 2) PATH: hsa0006210449ACAA2, DSAECMAACOAm -> ACCOAm + PROPCOAm2.3.1.1630ACAA1, ACAAMAACOA -> ACCOA + PROPCOA2.3.1.163032HADHBMAACOA -> ACCOA + PROPCOA2.3.1.163.3 Fatty acid metabolism PATH: hsa0007151ACOX1, ACOX1.3.3.633ACADL, LCAD1.3.99.132639GCDH1.3.99.72179FACL1, LACSATP + LCCA + COA <-> AMP + PPI + ACOA6.2.1.32180FACL2, FACL1, LACS2ATP + LCCA + COA <-> AMP + PPI + ACOA6.2.1.32182FACL4, ACS4ATP + LCCA + COA <-> AMP + PPI + ACOA6.2.1.31374CPT1A, CPT1, CPT1-L2.3.1.211375CPT1B, CPT1-M2.3.1.211376CPT2, CPT1, CPTASE2.3.1.211632DCI5.3.3.811283CYP4F81.14.14.11543CYP1A1, CYP11.14.14.11544CYP1A21.14.14.11545CYP1B1, GLC3A1.14.14.11548CYP2A6, CYP2A31.14.14.11549CYP2A71.14.14.11551CYP3A71.14.14.11553CYP2A131.14.14.11554CYP2B1.14.14.11555CYP2B61.14.14.11557CYP2C19, CYP2C, P450IIC191.14.14.11558CYP2C81.14.14.11559CYP2C9, P450IIC9, CYP2C101.14.14.11562CYP2C18, P450IIC17, CYP2C171.14.14.11565CYP2D61.14.14.11571CYP2E, CYP2E1, P450C2E1.14.14.11572CYP2F1, CYP2F1.14.14.11573CYP2J21.14.14.11575CYP3A31.14.14.11576CYP3A41.14.14.11577CYP3A5, PCN31.14.14.11580CYP4B11.14.14.11588CYP19, ARO1.14.14.11595CYP511.14.14.1194AHHR, AHH1.14.14.13.4 Synthesis and degradation of ketone bodies PATH: hsa000723.5 Sterol biosynthesis PATH: hsa001003156HMGCRMVL + COA + 2 NADP <-> H3MCOA + 2 NADPH1.1.1.344598MVK, MVLKATP + MVL -> ADP + PMVL2.7.1.36CTP + MVL -> CDP + PMVLGTP + MVL -> GDP + PMVLUTP + MVL -> UDP + PMVL10654PMVK, PMKASE, PMK, HUMPMKIATP + PMVL -> ADP + PPMVL2.7.4.24597MVD, MPDATP + PPMVL -> ADP + PI + IPPP + CO24.1.1.333422IDI1IPPP <-> DMPP5.3.3.22224FDPSGPP + IPPP -> FPP + PPI2.5.1.10DMPP + IPPP-> GPP + PPI2.5.1.19453GGPS1, GGPPSDMPP + IPPP -> GPP + PPI2.5.1.1GPP + IPPP -> FPP + PPI2.5.1.102.5.1.292222FDFT1; DGPT2 FPP + NADPH -> NADP + SQL2.5.1.216713SQLESQL + O2 + NADP -> S23E + NADPH1.14.99.74047LSS, OSCS23E -> LNST5.4.99.71728DIA4, NMOR1, NQO1, NMORI1.6.99.24835NMOR2, NQO21.6.99.237ACADVL, VLCAD, LCACD1.3.99.—3.6 Bile acid biosynthesis PATH: hsa001201056CEL, BSSL, BAL3.1.1.33988LIPA, LAL3.1.1.136646SOAT1, ACAT, STAT, SOAT, ACAT1,3.1.1.13ACACT2.3.1.261581CYP7A1, CYP71.14.13.176715SRD5A11.3.99.56716SRD5A21.3.99.56718AKR1D1, SRD5B1, 3o5bred1.3.99.6570BAAT, BAT2.3.1.653.7 C21-Steroid hormone metabolism PATH: hsa001401583CYP11A, P450SCC1.14.15.63283HSD3B1, HSD3B, HSDB3IMZYMST -> IIMZYMST + CO25.3.3.1IMZYMST -> IIZYMST + CO21.1.1.1453284HSD3B2IMZYMST -> IIMZYMST + CO25.3.3.1IMZYMST -> IIZYMST + CO21.1.1.1451589CYP21A2, CYP21, P450221B,1.14.99.10CA21H, CYP21B, P450c21B1586CYP17, P450C171.14.99.91584CYP11B1, P450C11, CYP11B1.14.15.41585CYP11B2, CYP11B1.14.15.43290HSD11B1, HSD11, HSD11L, HSD11B1.1.1.1463291HSD11B2, HSD11K1.1.1.1463.8 Androgen and estrogen metabolism PATH: hsa001503292HSD17B1, EDH17B2, EDHB17,1.1.1.62HSD173293HSD17B3, EDH17B31.1.1.623294HSD17B2, EDH17B21.1.1.623295HSD17B41.1.1.623296HSD17BP1, EDH17B1, EDHB17,1.1.1.62HSD1751478HSD17B7, PRAP1.1.1.62412STS, ARSC, ARSC1, SSDD3.1.6.2414ARSD3.1.6.1415ARSE, CDPX1, CDPXR, CDPX3.1.6.111185INMT2.1.1.—24140JM232.1.1.—29104N6AMT1, PRED282.1.1.—29960FJH12.1.1.—3276HRMT1L2, HCP1, PRMT12.1.1.—51628LOC516282.1.1.—54743HASJ44422.1.1.—27292HSA97612.1.1.—4. Nucleotide Metabolism4.1 Purine metabolism PATH: hsa0023011164NUDT5, HYSAH1, YSA1H3.6.1.135471PPAT, GPATPRPP + GLN -> PPI + GLU + PRAM2.4.2.142618GART, PGFT, PRGSPRAM + ATP + GLY <-> ADP + PI + GAR6.3.4.13FGAM + ATP -> ADP + PI + AIR6.3.3.1GAR + FTHF -> THF + FGAR2.1.2.25198PFAS, FGARAT, KIAA0361, PURLFGAR + ATP + GLN -> GLU + ADP + PI + FGAM6.3.5.310606ADE2H1CAIR + ATP + ASP <-> ADP + PI + SAICAR6.3.2.6CAIR <-> AIR + CO24.1.1.215059PAICS, AIRC, PAISCAIR + ATP + ASP <-> ADP + PI + SAICAR6.3.2.6158ADSLASUC <-> FUM + AMP4.3.2.2471ATIC, PURHAICAR + FTHF <-> THF + PRFICA2.1.2.3PRFICA <-> IMP3.5.4.103251HPRT1, HPRT, HGPRTHYXAN + PRPP -> PPI + IMP2.4.2.8GN + PRPP -> PPI + GMP3614IMPDH1IMP + NAD -> NADH + XMP1.1.1.2053615IMPDH2IMP + NAD -> NADH + XMP1.1.1.2058833GMPS6.3.5.21149232987GUK1GMP + ATP <-> GDP + ADP2.7.4.8DGMP + ATP <-> DGDP + ADPGMP + DATP <-> GDP + DADP2988GUK2GMP + ATP <-> GDP + ADP2.7.4.8DGMP + ATP <-> DGDP + ADPGMP + DATP <-> GDP + DADP10621RPC392.7.7.610622RPC322.7.7.610623RPC622.7.7.611128RPC1552.7.7.625885DKFZP586M01222.7.7.630834ZNRD12.7.7.651082LOC510822.7.7.651728LOC517282.7.7.65430POLR2A, RPOL2, POLR2, POLRA2.7.7.65431POLR2B, POL2RB2.7.7.65432POLR2C2.7.7.65433POLR2D, HSRBP4, HSRPB42.7.7.65434POLR2E, RPB5, XAP42.7.7.65435POLR2F, RPB6, HRBP14.42.7.7.65436POLR2G, RPB72.7.7.65437POLR2H, RPB8, RPB172.7.7.65438POLR2I2.7.7.65439POLR2J2.7.7.65440POLR2K, RPB7.02.7.7.65441POLR2L, RPB7.6, RPB102.7.7.65442POLRMT, APOLMT2.7.7.654479FLJ10816, Rpo1-22.7.7.655703FLJ103882.7.7.6661BN51T2.7.7.69533RPA40, RPA392.7.7.610721POLQ2.7.7.711232POLG2, MTPOLB, HP55, POLB2.7.7.723649POLA22.7.7.75422POLA2.7.7.75423POLB2.7.7.75424POLD1, POLD2.7.7.75425POLD22.7.7.75426POLE2.7.7.75427POLE22.7.7.75428POLG2.7.7.75980REV3L, POLZ, REV32.7.7.77498XDH1.1.3.229615GDA, KIAA1258, CYPIN, NEDASIN1.1.1.2042766GMPR3.5.4.351292LOC512921.6.6.87377UOX1.6.6.86240RRM1ADP + RTHIO -> DADP + OTHIO1.7.3.3GDP + RTHIO -> DGDP + OTHIO1.17.4.1CDP + RTHIO -> DCDP + OTHIOUDP + RTHIO -> DUDP + OTHIO6241RRM2ADP + RTHIO -> DADP + OTHIO1.17.4.1GDP + RTHIO -> DGDP + OTHIOCDP + RTHIO -> DCDP + OTHIOUDP + RTHIO -> DUDP + OTHIO4860NP, PNPAND + PI <-> AD + R1P2.4.2.1GSN + PI <-> GN + R1PDA + PI <-> AD + R1PDG + PI <-> GN + R1PDIN + PI <-> HYXAN + R1PINS + PI <-> HYXAN + R1PXTSINE + PI <-> XAN + R1P1890ECGF1, hPD-ECGFDU + PI <-> URA + DR1P2.4.2.4DT + PI <-> THY + DR1P353APRTAD + PRPP -> PPI + AMP2.4.2.7132ADKADN + ATP -> AMP + ADP2.7.1.201633DCK2.7.1.741716DGUOK2.7.1.113203AK1ATP + AMP <-> 2 ADP2.7.4.3GTP + AMP <-> ADP + GDPITP + AMP <-> ADP + IDP204AK2ATP + AMP <-> 2 ADP2.7.4.3GTP + AMP <-> ADP + GDPITP + AMP <-> ADP + IDP205AK3ATP + AMP <-> 2 ADP2.7.4.3GTP + AMP <-> ADP + GDPITP + AMP <-> ADP + IDP26289AK5ATP + AMP <-> 2 ADP2.7.4.3GTP + AMP <-> ADP + GDPITP + AMP <-> ADP + IDP4830NME1, NM23, NM23-H1UDP + ATP <-> UTP + ADP2.7.4.6CDP + ATP <-> CTP + ADPGDP + ATP <-> GTP + ADPIDP + ATP <-> ITP + IDPDGDP + ATP <-> DGTP + ADPDUDP + ATP <-> DUTP + ADPDCDP + ATP <-> DCTP + ADPDTDP + ATP <-> DTTP + ADPDADP + ATP <-> DATP + ADP4831NME2, NM23-H2UDP + ATP <-> UTP + ADP2.7.4.6CDP + ATP <-> CTP + ADPGDP + ATP <-> GTP + ADPIDP + ATP <-> ITP + IDPDGDP + ATP <-> DGTP + ADPDUDP + ATP <-> DUTP + ADPDCDP + ATP <-> DCTP + ADPDTDP + ATP <-> DTTP + ADPDADP + ATP <-> DATP + ADP4832NME3, DR-nm23, DR-NM23UDP + ATP <-> UTP + ADP2.7.4.6CDP + ATP <-> CTP + ADPGDP + ATP <-> GTP + ADPIDP + ATP <-> ITP + IDPDGDP + ATP <-> DGTP + ADPDUDP + ATP <-> DUTP + ADPDCDP + ATP <-> DCTP + ADPDTDP + ATP <-> DTTP + ADPDADP + ATP <-> DATP + ADP4833NME4UDPm + ATPm <-> UTPm + ADPm2.7.4.6CDPm + ATPm <-> CTPm + ADPmGDPm + ATPm <-> GTPm + ADPmIDPm + ATPm <-> ITPm + IDPmDGDPm + ATPm <-> DGTPm + ADPmDUDPm + ATPm <-> DUTPm + ADPmDCDPm + ATPm <-> DCTPm + ADPmDTDPm + ATPm <-> DTTPm + ADPmDADPm + ATPm <-> DATPm + ADPm22978NT5B, PNT5, NT5B-PENDINGAMP + H2O -> PI + ADN3.1.3.5GMP -> PI + GSNCMP -> CYTD + PIUMP -> PI + URIIMP -> PI + INSDUMP -> DU + PIDTMP -> DT + PIDAMP -> DA + PIDGMP -> DG + PIDCMP -> DC + PIXMP -> PI + XTSINE4877NT3AMP -> PI + ADN3.1.3.5GMP -> PI + GSNCMP -> CYTD + PIUMP -> PI + URIIMP -> PI + INSDUMP -> DU + PIDTMP -> DT + PIDAMP -> DA + PIDGMP -> DG + PIDCMP -> DC + PIXMP -> PI + XTSINE4907NT5, CD73AMP -> PI + ADN3.1.3.5GMP -> PI + GSNCMP -> CYTD + PIUMP -> PI + URIIMP -> PI + INSDUMP -> DU + PIDTMP -> DT + PIDAMP -> DA + PIDGMP -> DG + PIDCMP -> DC + PIXMP -> PI + XTSINE7370UMPH2AMP -> PI + ADN3.1.3.5GMP -> PI + GSNCMP -> CYTD + PIUMP -> PI + URIIMP -> PI + INSDUMP -> DU + PIDTMP -> DT + PIDAMP -> DA + PIDGMP -> DG + PIDCMP -> DC + PIXMP -> PI + XTSINE10846PDE10AcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP27115PDE7BcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5136PDE1AcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5137PDE1C, HCAM3cAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5138PDE2AcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5139PDE3A, CGI-PDEcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5140PDE3BcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5141PDE4A, DPDE2cAMP -> AMP3.1.4.175142PDE4B, DPDE4, PDEIVBcAMP -> AMP3.1.4.175143PDE4C, DPDE1cAMP -> AMP3.1.4.175144PDE4D, DPDE3cAMP -> AMP3.1.4.175145PDE6A, PDEA, CGPR-AcGMP -> GMP3.1.4.175146PDE6C, PDEA2cGMP -> GMP3.1.4.175147PDE6DcGMP -> GMP3.1.4.175148PDE6G, PDEGcGMP -> GMP3.1.4.175149PDE6HcGMP -> GMP3.1.4.175152PDE9AcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5153PDES1BcAMP -> AMP3.1.4.17cAMP -> AMPcdAMP -> dAMPcIMP -> IMPcGMP -> GMPcCMP -> CMP5158PDE6B, CSNB3, PDEBcGMP -> GMP3.1.4.178654PDE5AcGMP -> GMP3.1.4.17100ADAADN -> INS + NH33.5.4.4DA -> DIN + NH3270AMPD1, MADAAMP -> IMP + NH33.5.4.6271AMPD2AMP -> IMP + NH33.5.4.6272AMPD3AMP -> IMP + NH33.5.4.6953ENTPD1, CD393.6.1.53704ITPA3.6.1.19107ADCY1ATP -> cAMP + PPI4.6.1.1108ADCY2, HBAC2ATP -> cAMP + PPI4.6.1.1109ADCY3, AC3, KIAA0511ATP -> cAMP + PPI4.6.1.1110ADCY4ATP -> cAMP + PPI4.6.1.1111ADCY5ATP -> cAMP + PPI4.6.1.1112ADCY6ATP -> cAMP + PPI4.6.1.1113ADCY7, KIAA0037ATP -> cAMP + PPI4.6.1.1114ADCY8, ADCY3, HBAC1ATP -> cAMP + PPI4.6.1.1115ADCY9ATP -> cAMP + PPI4.6.1.12977GUCY1A2, GUC1A2, GC-SA24.6.1.22982GUCY1A3, GUC1A3, GUCSA3, GC-4.6.1.2SA32983GUCY1B3, GUC1B3, GUCSB3, GC-4.6.1.2SB32984GUCY2C, GUC2C, STAR4.6.1.22986GUCY2F, GUC2F, GC-F, GUC2DL,4.6.1.2RETGC-23000GUCY2D, CORD6, GUC2D, LCA1,4.6.1.2GUC1A4, LCA, retGC4881NPR1, ANPRA, GUC2A, NPRA4.6.1.24882NPR2, ANPRB, GUC2B, NPRB,4.6.1.2NPRBi159ADSSIMP + GTP + ASP -> GDP + PI + ASUC6.3.4.4318NUDT2, APAH13.6.1.175167ENPP1, M6S1, NPPS, PCA1, PC-1,3.6.1.9PDNP15168ENPP2, ATX, PD-IALPHA, PDNP23.6.1.95169ENPP3, PD-IBETA, PDNP33.6.1.93.1.4.12272FHIT3.6.1.294.2 Pyrimidine metabolism PATH: hsa00240790CADGLN + 2 ATP + CO2 -> GLU + CAP + 2 ADP + PI6.3.5.5CAP + ASP -> CAASP + PI2.1.3.2CAASP <-> DOROA3.5.2.31723DHODHDOROA + O2 <-> H2O2 + OROA1.3.3.17372UMPS, OPRTOMP -> CO2 + UMP4.1.1.23OROA + PRPP <-> PPI + OMP2.4.2.1051727LOC51727ATP + UMP <-> ADP + UDP2.7.4.14CMP + ATP <-> ADP + CDPDCMP + ATP <-> ADP + DCDP50808AKL3L2.7.4.101503CTPSUTP + GLN + ATP -> GLU + CTP + ADP + PI6.3.4.2ATP + UTP + NH3 -> ADP + PI + CTP7371UMPK, TSA903URI + ATP -> ADP + UMP2.7.1.48URI + GTP -> UMP + GDPCYTD + GTP -> GDP + CMP7378UPURI + PI <-> URA + R1P2.4.2.31806DPYD, DPD1.3.1.21807DPYS, DHPase, DHPASE, DHP3.5.2.251733LOC517333.5.1.67296TXNRD1, TXNROTHIO + NADPH -> NADP + RTHIO1.6.4.51854DUTDUTP -> PPI + DUMP3.6.1.237298TYMS, TMS, TSDUMP + METTHF -> DHF + DTMP2.1.1.45978CDA, CDDCYTD -> URI + NH33.5.4.5DC -> NH3 + DU1635DCTDDCMP <-> DUMP + NH33.5.4.127083TK1DU + ATP -> DUMP + ADP2.7.1.21DT + ATP -> ADP + DTMP7084TK2DUm + ATPm -> DUMPm + ADPm2.7.1.21DTm + ATPm -> ADPm + DTMPm1841DTYMK, TYMK, CDC8DTMP + ATP <-> ADP + DTDP2.7.4.94.3 Nucleotide sugars metabolism PATH: hsa0052023483TDPGD4.2.1.461486CTBS, CTB3.2.1.—5. Amino Acid Metabolism5.1 Glutamate metabolism PATH: hsa002518659ALDH4, P5CDHP5C + NAD + H2O -> NADH + GLU1.5.1.122058EPRS, QARS, QPRSGLU + ATP -> GTRNA + AMP + PPI6.1.1.176.1.1.152673GFPT1, GFA, GFAT, GFPTF6P + GLN -> GLU + GA6P2.6.1.169945GFPT2, GFAT2F6P + GLN -> GLU + GA6P2.6.1.165859QARS6.1.1.182729GLCLC, GCS, GLCLCYS + GLU + ATP -> GC + PI + ADP6.3.2.22730GLCLRCYS + GLU + ATP -> GC + PI + ADP6.3.2.22937GSS, GSHSGLY + GC + ATP -> RGT + PI + ADP6.3.2.32936GSRNADPH + OGT -> NADP + RGT1.6.4.25188PET112L, PET1126.3.5.—5.2 Alanine and aspartate metabolism PATH: hsa002524677NARS, ASNRSATP + ASP + TRNA -> AMP + PPI + ASPTRNA6.1.1.22435ASLARGSUCC -> FUM + ARG4.3.2.1189AGXT, SPATSERm + PYRm <-> ALAm + 3HPm2.6.1.51ALA + GLX <-> PYR + GLY2.6.1.4416AARS6.1.1.71615DARS6.1.1.12445ASS, CTLN1, ASS1CITR + ASP + ATP <-> AMP + PPI + ARGSUCC6.3.4.5443ASPA, ASP, ACY23.5.1.151384CRAT, CAT12.3.1.7ACCOA + CAR -> COA + ACAR8528DDO1.4.3.15.3 Glycine, serine and threonine metabolism PATH: hsa002605723PSPH, PSP3PSER + H2O -> PI + SER3.1.3.329968PSAPHP + GLU <-> AKG + 3PSER2.6.1.52OHB + GLU <-> PHT + AKG26227PHGDH, SERA, PGDH, PGD, PGAD3PG + NAD <-> NADH + PHP1.1.1.9523464GCAT, KBL2.3.1.29211ALAS1, ALASSUCCOA + GLY -> ALAV + COA + CO22.3.1.37212ALAS2, ANH1, ASBSUCCOA + GLY -> ALAV + COA + CO22.3.1.374128MAOAAMA + H2O + FAD -> NH3 + FADH2 + MTHGXL1.4.3.44129MAOBAMA + H2O + FAD -> NH3 + FADH2 + MTHGXL1.4.3.426ABP1, AOC1, DAO1.4.3.6314AOC2, DAO2, RAO1.4.3.68639AOC3, VAP-1, VAP1, HPAO1.4.3.62731GLDCGLY + LIPO <-> SAP + CO21.4.4.21610DAO, DAMOX1.4.3.32617GARS6.1.1.142628GATM2.1.4.12593GAMT2.1.1.2PISD, PSSC, DKFZP566G2246,PS -> PE + CO223761DJ858B164.1.1.65635BHMT2.1.1.529958DMGDH1.5.99.2875CBSSER + HCYS -> LLCT + H2O4.2.1.226301SARS, SERS6.1.1.1110993SDS, SDHSER -> PYR + NH3 + H2O4.2.1.136897TARS6.1.1.35.4 Methionine metabolism PATH: hsa002714143MAT1A, MATA1, SAMS1, MAT, SAMSMET + ATP + H2O -> PPI + PI + SAM2.5.1.64144MAT2A, MATA2, SAMS2, MATIIMET + ATP + H2O -> PPI + PI + SAM2.5.1.61786DNMT1, MCMT, DNMTSAM + DNA-> SAH + DNA5MC2.1.1.3710768AHCYL1, XPVKONASAH + H2O -> HCYS + ADN3.3.1.1191AHCY, SAHHSAH + H2O -> HCYS + ADN3.3.1.14141MARS, METRS, MTRNS6.1.1.104548MTRHCYS + MTHF -> THF + MET2.1.1.135.5 Cysteine metabolism PATH: hsa00272833CARS6.1.1.161036CDO1CYS + O2 <-> CYSS1.13.11.208509NDST2, HSST2, NST22.8.2.—5.6 Valine, leucine and isoleucine degradation PATH: hsa00280586BCAT1, BCT1, ECA39, MECA39AKG + ILE -> OMVAL + GLU2.6.1.42AKG + VAL -> OIVAL + GLUAKG + LEU -> OICAP + GLU587BCAT2, BCT2OICAPm + GLUm <-> AKGm + LEUm2.6.1.42OMVALm + GLUm <-> AKGm + ILEm5014OVD1A1.2.4.4593BCKDHA, MSUD1OMVALm + COAm + NADm -> MBCOAm + NADHm + CO2m1.2.4.4OIVALm + COAm + NADm -> IBCOAm + NADHm + CO2mOICAPm + COAm + NADm -> IVOCAm + NADHm + CO2m594BCKDHB, E1BOMVALm + COAm + NADm -> MBCOAm + NADHm + CO2m1.2.4.4OIVALm + COAm + NADm -> IBCOAm + NADHm + CO2mOICAPm + COAm + NADH -> IVCOAm + NADHm + CO2m3712IVDIVCOAm + FADm -> MCRCOAm + FADH2m1.3.99.10316AOX1, AO1.2.3.14164MCCC1MCRCOAm + ATPm + CO2m + H2Om -> MGCOAm + ADPm +6.4.1.4Pim4165MCCC2MCRCOAm + ATPm + CO2m + H2Om -> MGCOAm + ADPm +6.4.1.4Pim5.7 Valine, leucine and isoleucine biosynthesis PATH: hsa0029023395KIAA0028, LARS26.4.1.43926LARS6.4.1.43376IARS, ILRS6.1.1.57406VARS1, VARS6.1.1.97407VARS2, G7A6.1.1.95.8 Lysine biosynthesis PATH: hsa003003735KARS, KIAA0070ATP + LYS + LTRNA -> AMP + PPI + LLTRNA6.1.1.65.9 Lysine degradation PATH: hsa003108424BBOX, BBH, GAMMA-BBH, G-BBH1.14.11.15351PLOD, LLH1.14.11.45352PLOD21.14.11.48985PLOD3, LH31.14.11.410157LKR/SDH, AASSLYS + NADPH + AKG -> NADP + H2O + SAC1.5.1.9SAC + H2O + NAD -> GLU + NADH + AASA5.10 Arginine and proline metabolism PATH: hsa003305009OTCORNm + CAPm -> CITRm + Pim + Hm2.1.3.3383ARG1ARG -> ORN + UREA3.5.3.1384ARG2ARG -> ORN + UREA3.5.3.14842NOS1, NOS1.14.13.394843NOS2A, NOS21.14.13.394846NOS3, ECNOS1.14.13.394942OATORN + AKG <-> GLUGSAL + GLU2.6.1.135831PYCR1, P5C, PYCRP5C + NADPH -> PRO + NADP1.5.1.2P5C + NADH -> PRO + NADPHC + NADPH -> HPRO + NADPPHC + NADH -> HPRO + NAD5033P4HA1, P4HA1.14.11.25917RARSATP + ARG + ATRNA -> AMP + PPI + ALTRNA6.1.1.191152CKB, CKBBPCRE + ADP -> CRE + ATP2.7.3.21156CKBE2.7.3.21158CKM, CKMM2.7.3.21159CKMT1, CKMT, UMTCK2.7.3.21160CKMT2, SMTCK2.7.3.26723SRM, SPS1, SRML1PTRSC + SAM -> SPRMD + 5MTA2.5.1.16262AMD1, ADOMETDCSAM <-> DSAM + CO24.1.1.50263AMDP1, AMD, AMD2SAM <-> DSAM + CO24.1.1.501725DHPSSPRMD + Qm -> DAPRP + QH2m1.5.99.66611SMSDSAM + SPRMD -> 5MTA + SPRM2.5.1.224953ODC1ORN -> PTRSC + CO24.1.1.176303SAT, SSAT2.3.1.575.11 Histidine metabolism PATH: hsa0034010841FTCDFIGLU + THF -> NFTHF + GLU2.1.2.54.3.1.43067HDC4.1.1.221644DDC, AADC4.1.1.283176HNMT2.1.1.8218ALDH3ACAL + NAD -> NADH + AC1.2.1.5220ALDH6ACAL + NAD -> NADH + AC1.2.1.5221ALDH7, ALDH4ACAL + NAD -> NADH + AC1.2.1.5222ALDH8ACAL + NAD -> NADH + AC1.2.1.53035HARSATP + HIS + HTRNA -> AMP + PPI + HHTRNA6.1.1.215.12 Tyrosine metabolism PATH: hsa003506898TATAKG + TYR -> HPHPYR + GLU2.6.1.53242HPD, PPDHPHPYR + O2 -> HGTS + CO21.13.11.273081HGD, AKU, HGOHGTS + O2 -> MACA1.13.11.52954GSTZ1, MAAIMACA -> FACA5.2.1.22.5.1.182184FAHFACA + H2O -> FUM + ACA3.7.1.27299TYR, OCAIA1.14.18.17054TH, TYH1.14.16.21621DBH1.14.17.15409PNMT, PENT2.1.1.281312COMT2.1.1.67173TPO, TPX1.11.1.85.13 Phenylalanine metabolism PATH: hsa00360501ATQ11.2.1.—5.14 Tryptophan metabolism PATH: hsa003806999TDO2, TPH2, TRPO, TDOTRP + O2 -> FKYN1.13.11.118564KMOKYN + NADPH + O2 -> HKYN + NADP + H2O1.14.13.98942KYNUKYN -> ALA + AN3.7.1.3HKYN + H2O -> HAN + ALA23498HAAO, HAO, 3-HAOHAN + O2 -> CMUSA1.13.11.67166TPH, TPRH1.14.16.4438ASMT, HIOMT, ASMTY2.1.1.415AANAT, SNAT2.3.1.873620INDO, IDO1.13.11.4210352WARS2ATPm + TRPm + TRNAm -> AMPm + PPIm + TRPTRNAm6.1.1.27453WARS, IFP53, IFI53, GAMMA-2ATP + TRP + TRNA -> AMP + PPI + TRPTRNA6.1.1.24734NEDD4, KIAA00936.3.2.—5.15 Phenylalanine, tyrosine and tryptophan biosynthesis PATH: hsa004005053PAH, PKU1PHE + THBP + O2 -> TYR + DHBP + H2O1.14.16.110667FARS16.1.1.202193FARSL, CML336.1.1.2010056PheHB6.1.1.208565YARS, TYRRS, YTS, YRS6.1.1.15.16 Urea cycle and metabolism of amino groups PATH: hsa002205832PYCSGLUP + NADH -> NAD + PI + GLUGSAL2.7.2.11GLUP + NADPH -> NADP + PI + GLUGSAL1.2.1.4195ACY13.5.1.146. Metabolism of Other Amino Acids6.1 beta-Alanine metabolism PATH: hsa004106.2 Taurine and hypotaurine metabolism PATH: hsa004302678GGT1, GTG, D22S672, D22S732,RGT + ALA -> CGLY + ALAGLY2.3.2.2GGT2679GGT2, GGTRGT + ALA -> CGLY + ALAGLY2.3.2.22680GGT3RGT + ALA -> CGLY + ALAGLY2.3.2.22687GGTLA1, GGT-REL, DKFZP566O011RGT + ALA -> CGLY + ALAGLY2.3.2.26.3 Aminophosphonate metabolism PATH: hsa004405130PCYT1A, CTPCT, CT, PCYT1PCHO + CTP -> CDPCHO + PPI2.7.7.159791PTDSS1, KIAA0024, PSSACDPDG + SER <-> CMP + PS2.7.8.—6.4 Selenoamino acid metabolism PATH: hsa0045022928SPS22.7.9.322929SPS, SELD2.7.9.36.5 Cyanoamino acid metabolism PATH: hsa004606.6 D-Glutamine and D-glutamate metabolism PATH: hsa004716.7 D-Arginine and D-ornithine metabolism PATH: hsa004726.9 Glutathione metabolism PATH: hsa004805182PEPB3.4.11.42655GCTG2.3.2.42876GPX1, GSHPX12 RGT + H2O2 <-> OGT1.11.1.92877GPX2, GSHPX-GI2 RGT + H2O2 <-> OGT1.11.1.92878GPX32 RGT + H2O2 <-> OGT1.11.1.92879GPX42 RGT + H2O2 <-> OGT1.11.1.92880GPX52 RGT + H2O2 <-> OGT1.11.1.92881GPX62 RGT + H2O2 <-> OGT1.11.1.92938GSTA12.5.1.182939GSTA2, GST22.5.1.182940GSTA32.5.1.182941GSTA42.5.1.182944GSTM1, GST1, MU2.5.1.182946GSTM2, GST42.5.1.182947GSTM3, GST52.5.1.182948GSTM42.5.1.182949GSTM52.5.1.182950GSTP1, FAEES3, DFN7, GST3, PI2.5.1.182952GSTT12.5.1.182953GSTT22.5.1.184257MGST1, GST12, MGST, MGST-I2.5.1.184258MGST2, GST2, MGST-II2.5.1.184259MGST3, GST-III2.5.1.187. Metabolism of Complex Carbohydrates7.1 Starch and sucrose metabolism PATH: hsa005006476SI3.2.1.103.2.1.4811181TREH, TRE, TREATRE -> 2 GLC3.2.1.282990GUSB3.2.1.312632GBE1GLYCOGEN + PI -> G1P2.4.1.185834PYGBGLYCOGEN + PI -> G1P2.4.1.15836PYGLGLYCOGEN + PI -> G1P2.4.1.15837PYGMGLYCOGEN + PI -> G1P2.4.1.12997GYS1, GYSUDPG -> UDP + GLYCOGEN2.4.1.112998GYS2UDPG -> UDP + GLYCOGEN2.4.1.11276AMY1A, AMY13.2.1.1277AMY1B, AMY13.2.1.1278AMY1C, AMY13.2.1.1279AMY2A, AMY23.2.1.1280AMY2B, AMY23.2.1.1178AGL, GDE2.4.1.253.2.1.3310000AKT3, PKBG, RAC-GAMMA, PRKBG2.7.1.—1017CDK22.7.1.—1018CDK32.7.1.—1019CDK4, PSK-J32.7.1.—1020CDK5, PSSALRE2.7.1.—1021CDK6, PLSTIRE2.7.1.—1022CDK7, CAK1, STK1, CDKN72.7.1.—1024CDK8, K352.7.1.—1025CDK9, PITALRE, CDC2L42.7.1.—10298PAK42.7.1.—10746MAP3K2, MEKK22.7.1.—1111CHEK1, CHK12.7.1.—11200RAD53, CHK2, CDS1, HUCDS12.7.1.—1195CLK1, CLK2.7.1.—1326MAP3K8, COT, EST, ESTF, TPL-22.7.1.—1432MAPK14, CSBP2, CSPB1, PRKM14,2.7.1.—PRKM15, CSBP1, P38, MXI21452CSNK1A12.7.1.—1453CSNK1D, HCKID2.7.1.—1454CSNK1E, HCKIE2.7.1.—1455CSNK1G22.7.1.—1456CSNK1G32.7.1.—1612DAPK1, DAPK2.7.1.—1760DMPK, DM, DMK, DM12.7.1.—1859DYRK1A, DYRK1, DYRK,2.7.1.—MNB, MNBH208AKT2, RAG-BETA, PRKBB, PKBBETA2.7.1.—269AMHR2, AMHR2.7.1.—27330RPS6KA6, RSK42.7.1.—2868GPRK2L, GPRK42.7.1.—2869GPRK5, GRK52.7.1.—2870GPRK6, GRK62.7.1.—29904HSU938502.7.1.—30811HUNK2.7.1.—3611ILK, P592.7.1.—3654IRAK1, IRAK2.7.1.—369ARAF1, PKS2, RAFA12.7.1.—370ARAF2P, PKS1, ARAF22.7.1.—3984LIMK1, LIMK2.7.1.—3985LIMK22.7.1.—4117MAK2.7.1.—4140MARK3, KP782.7.1.—4215MAP3K3, MAPKKK3, MEKK32.7.1.—4216MAP3K4, MAPKKK4, MTK1, MEKK4,2.7.1.—KIAA02134217MAP3K5, ASK1, MAPKKK5, MEKK52.7.1.—4293MAP3K9, PRKE1, MLK12.7.1.—4294MAP3K10, MLK2, MST2.7.1.—4342MOS2.7.1.—4751NEK2, NLK12.7.1.—4752NEK32.7.1.—5058PAK1, PAKalpha2.7.1.—5062PAK2, PAK65, PAKgamma2.7.1.—5063PAK3, MRX30, PAK3beta2.7.1.—5127PCTK1, PCTGAIRE2.7.1.—5128PCTK22.7.1.—5129PCTK3, PCTAIRE2.7.1.—5292PIM1, PIM2.7.1.—5347PLK, PLK12.7.1.—5562PRKAA12.7.1.—5563PRKAA2, AMPK, PRKAA2.7.1.—5578PRKCA, PKCA2.7.1.—5579PRKCB1, PKCB, PRKCB, PRKCB22.7.1.—5580PRKCD2.7.1.—5581PRKCE2.7.1.—5582PRKCG, PKCC, PKCG2.7.1.—5583PRKCH, PKC-L, PRKCL2.7.1.—5584PRKCI, DXS1179E, PKCI2.7.1.—5585PRKCL1, PAK1, PRK1, DBK, PKN2.7.1.—5586PRKCL2, PRK22.7.1.—5588PRKCQ2.7.1.—5590PRKCZ2.7.1.—MAPK1, PRKM1, P41MAPK,5594P42MAPK, ERK2, ERK, MAPK2,2.7.1.—PRKM25595MAPK3, ERK1, PRKM3, P44ERK1,2.7.1.—P44MAPK5597MAPK6, PRKM6, P97MAPK, ERK32.7.1.—5598MAPK7, BMK1, ERK5, PRKM72.7.1.—5599MAPK8, JNK, JNK1, SAPK1, PRKM8,2.7.1.—JNK1A25601MAPK9, JNK2, PRKM9, P54ASAPK,2.7.1.—JUNKINASE5602MAPK10, JNK3, PRKM10, P493F12,2.7.1.—P54BSAPK5603MAPK13, SAPK4, PRKM13,2.7.1.—P38DELTA5604MAP2K1, MAPKK1, MEK1, MKK1,2.7.1.—PRKMK15605MAP2K2, MEK2, PRKMK22.7.1.—5606MAP2K3, MEK3, MKK3, PRKMK32.7.1.—5607MAP2K5, MEK5, PRKMK52.7.1.—5608MAP2K6, MEK6, MKK6, SAPKK3,2.7.1.—PRKMK65609MAP2K7, MAPKK7, MKK7, PRKMK7,2.7.1.—JNKK25610PRKR, EIF2AK1, PKR2.7.1.—5613PRKX, PKX12.7.1.—5894RAF12.7.1.—613BCR, CML, PHL, BCR1, D22S11,2.7.1.—D22S6626195RPS6KA1, HU-1, RSK, RSK1,2.7.1.—MAPKAPK1A6196RPS6KA2, HU-2, MAPKAPK1C, RSK,2.7.1.—RSK36197RPS6KA3, RSK2, HU-2, HU-3, RSK,2.7.1.—MAPKAPK1B, ISPK-16198RPS6KB1, STK14A2.7.1.—6199RPS6KB2, P70-BETA, P70S6KB2.7.1.—6300MAPK12, ERK6, PRKM12, SAPK3,2.7.1.—P38GAMMA, SAPK-36416MAP2K4, JNKK1, MEK4, PRKMK4,2.7.1.—SERK1, MKK46446SGK2.7.1.—658BMPR1B, ALK-6, ALK62.7.1.—659BMPR2, BMPR-II, BMPR3, BRK-32.7.1.—673BRAF2.7.1.—6792STK92.7.1.—6794STK11, LKB1, PJS2.7.1.—6885MAP3K7, TAK12.7.1.—699BUB12.7.1.—701BUB1B, BUBR1, MAD3L2.7.1.—7016TESK12.7.1.—7272TTK, MPS1L12.7.1.—7867MAPKAPK3, 3PK, MAPKAP32.7.1.—8408ULK12.7.1.—8558CDK10, PISSLRE2.7.1.—8621CDC2L5, CDC2L, CHED2.7.1.—8737RIPK1, RIP2.7.1.—8814CDKL1, KKIALRE2.7.1.—8899PRP4, PR4H2.7.1.—9064MAP3K6, MAPKKK62.7.1.—9149DYRK1B2.7.1.—92ACVR2, ACTRII2.7.1.—9201DCAMKL1, KIAA03692.7.1.—93ACVR2B2.7.1.—983CDC22.7.1.—984CDC2L12.7.1.—5205FIC1, BRIC, PFIC1, PFIC, ATP8B13.6.1.—DHPP -> DHP + PIGTP -> GSN + 3 PIDGTP -> DG + 3 PI7.2 Glycoprotein biosynthesis PATH: hsa005101798DPAGT1, DPAGT, UGAT, UAGT,2.7.8.15D11S366, DGPT, DPAGT2, GPT29880ALG52.4.1.1178813DPM1GDPMAN + DOLP -> GDP + DOLMANP2.4.1.831650DDOST, OST, OST48, KIAA01152.4.1.1196184RPN12.4.1.1196185RPN22.4.1.11910130P55.3.4.110954PDIR5.3.4.111008PDI5.3.4.12923GRP58, ERp57, ERp60, ERp61,5.3.4.1GRP57, P58, PI-PLC, ERP57, ERP60,ERP615034P4HB, PROHB, PO4DB, ERBA2L5.3.4.17841GCS13.2.1.1064121MAN1A1, MAN9, HUMM93.2.1.1134245MGAT1, GLYT1, GLCNAC-TI, GNT-I,2.4.1.101MGAT4122MAN2A2, MANA2X3.2.1.1144124MAN2A1, MANA23.2.1.1144247MGAT2, CDGS2, GNT-II, GLCNACTII,2.4.1.143GNT24248MGAT3, GNT-III2.4.1.1446487SIAT6, ST3GALII2.4.99.66480SIAT12.4.99.12339FNTA, FPTA, PGGT1A2.5.1.—2342FNTB, FPTB2.5.1.—5229PGGT1B, BGGI, GGTI2.5.1.—5875RABGGTA2.5.1.—5876RABGGTB2.5.1.—1352COX102.5.1.—7.3 Glycoprotein degradation PATH: hsa005114758NEU1, NEU3.2.1.183073HEXA, TSD3.2.1.523074HEXB3.2.1.524123MAN2C1, MANA, MANA1, MAN6A83.2.1.244125MAN2B1, MANB, LAMAN3.2.1.244126MANBA, MANB13.2.1.252517FUCA13.2.1.512519FUCA23.2.1.51175AGA, AGU3.5.1.267.4 Aminosugars metabolism PATH: hsa005306675UAP1, SPAG2, AGX1UTP + NAGA1P <-> UDPNAG + PPI2.7.7.2310020GNE, GLCNE5.1.3.1422951CMAS2.7.7.431727DIA11.6.2.24669NAGLU, NAG3.2.1.507.5 Lipopolysaccharide biosynthesis PATH: hsa005406485SIAT5, SAT3, STZ2.4.99.—7903SIAT8D, PST, PST1, ST8SIA-IV2.4.99.—8128SIAT8B, STX, ST8SIA-II2.4.99.—7.7 Glycosaminoglycan degradation PATH: hsa005313423IDS, MPS2, SIDS3.1.6.133425IDUA, IDA3.2.1.76411ARSB3.1.6.122799GNS, G6S3.1.6.142588GALNS, MPS4A, GALNAC6S, GAS3.1.6.48. Metabolism of Complex Lipids8.1 Glycerolipid metabolism PATH: hsa0056110554AGPAT1, LPAAT-ALPHA, G15AGL3P + 0.017 C100ACP + 0.062 C120ACP + 0.100 C140ACP + 0.2702.3.1.51C160ACP + 0.169 C161ACP + 0.055 C180ACP + 0.235C181ACP + 0.093 C182ACP -> PA + ACP10555AGPAT2, LPAAT-BETAAGL3P + 0.017 C100ACP + 0.062 C120ACP + 0.100 C140ACP + 0.2702.3.1.51C160ACP + 0.169 C161ACP + 0.055 C180ACP + 0.235C181ACP + 0.093 C182ACP -> PA + ACP1606DGKA, DAGK, DAGK12.7.1.1071608DGKG, DAGK32.7.1.1071609DGKQ, DAGK42.7.1.1078525DGKZ, DAGK5, HDGKZETA2.7.1.1078526DGKE, DAGK6, DGK2.7.1.1078527DGKD, DGKDELTA, KIAA01452.7.1.1071120CHKLATP + CHO -> ADP + PCHO2.7.1.32EKI1ATP + ETHM -> ADP + PETHM2.7.1.821119CHK, CKIATP + CHO -> ADP + PCHO2.7.1.3243ACHE, YT3.1.1.71103CHAT2.3.1.65337PLD13.1.4.426279PLA2G2D, SPLA2S3.1.1.430814PLA2G2E3.1.1.45319PLA2G1B, PLA2, PLA2A, PPLA23.1.1.45320PLA2G2A, MOM1, PLA2B, PLA2L3.1.1.45322PLA2G53.1.1.48398PLA2G6, IPLA23.1.1.48399PLA2G10, SPLA23.1.1.41040CDS1PA + CTP <-> CDPDG + PPI2.7.7.4110423PISCDPDG + MYOI -> CMP + PINS2.7.8.112710GKGL + ATP -> GL3P + ADP2.7.1.302820GPD2GL3Pm + FADm -> T3P2m + FADH2m1.1.99.52819GPD1T3P2 + NADH <-> GL3P + NAD1.1.1.8248ALPIAHTD -> DHP + 3 PI3.1.3.1249ALPL, HOPS, TNSALPAHTD -> DHP + 3 PI3.1.3.1250ALPPAHTD -> DHP + 3 PI3.1.3.1251ALPPL2AHTD -> DHP + 3 PI3.1.3.1439ASNA1, ARSA-I3.6.1.168694DGAT, ARGP1DAGLY + 0.017 C100ACP + 0.062 C120ACP + 0.100 C140ACP + 0.2702.3.1.20C160ACP + 0.169 C161ACP + 0.055 C180ACP + 0.235C181ACP + 0.093 C182ACP -> TAGLY + ACP3989LIPB3.1.1.33990LIPC, HL3.1.1.35406PNLIP3.1.1.35407PNLIPRP1, PLRP13.1.1.35408PNLIPRP2, PLRP23.1.1.38513LIPF, HGL, HLAL3.1.1.34023LPL, LIPD3.1.1.348443GNPAT, DHAPAT, DAP-AT2.3.1.428540AGPS, ADAP-S, ADAS, ADHAPS,2.5.1.26ADPS, ALDHPSY4186MDCR, MDS, LIS13.1.1.475048PAFAH1B1, LIS1, MDCR, PAFAH3.1.1.475049PAFAH1B23.1.1.475050PAFAH1B33.1.1.475051PAFAH2, HSD-PLA23.1.1.477941PLA2G7, PAFAH, LDL-PLA23.1.1.478.2 Inositol phosphate metabolism PATH: hsa005625290PIK3CAATP + PINS -> ADP + PINSP2.7.1.1375291PIK3CB, PIK3C1ATP + PINS -> ADP + PINSP2.7.1.1375293PIK3CDATP + PINS -> ADP + PINSP2.7.1.1375294PIK3CGATP + PINS -> ADP + PINSP2.7.1.1375297PIK4CA, PI4K-ALPHAATP + PINS -> ADP + PINS4P2.7.1.675305PIP5K2APINS4P + ATP -> D45PI + ADP2.7.1.685330PLCB2D45PI -> TPI + DAGLY3.1.4.115331PLCB3D45PI -> TPI + DAGLY3.1.4.115333PLCD1D45PI -> TPI + DAGLY3.1.4.115335PLCG1, PLC1D45PI -> TPI + DAGLY3.1.4.115336PLCG2D45PI -> TPI + DAGLY3.1.4.113612IMPA1, IMPAMI1P -> MYOI + PI3.1.3.253613IMPA2MI1P -> MYOI + PI3.1.3.253628INPP13.1.3.573632INPP5A3633INPP5B3.1.3.563636INPPL1, SHIP23.1.3.564952OCRL, LOCR, OCRL1, INPP5F3.1.3.568867SYNJ1, INPP5G3.1.3.563706ITPKA2.7.1.12751477ISYNA1G6P -> MI1P5.5.1.43631INPP4A, INPP43.1.3.668821INPP4B3.1.3.668.3 Sphingophospholipid biosynthesis PATH: hsa005706609SMPD1, NPD3.1.4.128.4 Phospholipid degradation PATH: hsa005801178CLC3.1.1.55321PLA2G4A, CPLA2-ALPHA, PLA2G43.1.1.58.5 Sphingoglycolipid metabolism PATH: hsa0060010558SPTLC1, LCB1, SPTIPALCOA + SER -> COA + DHSPH + CO22.3.1.509517SPTLC2, KIAA0526, LCB2PALCOA + SER -> COA + DHSPH + CO22.3.1.50427ASAH, AC, PHP323.5.1.237357UGCG, GCS2.4.1.802629GDA G UC3.2.1.452583GALGT, GALNACT2.4.1.926489SIAT8A, SIAT8, ST8SIA-I2.4.99.86481SIAT22.4.99.24668NAGA, D22S674, GALB3.2.1.499514CST2.8.2.11410ARSA, MLD3.1.6.88.6 Blood group glycolipid biosynthesis —lact series PATH: hsa0060128ABO2.4.1.402.4.1.372525FUT3, LE2.4.1.652527FUT5, FUC-TV2.4.1.652528FUT6 2.4.1.652523FUT1, H, HH2.4.1.692524FUT2, SE2.4.1.698.7 Blood group glycolipid biosynthesis —neolact series PATH: hsa006022651GCNT2, IGNT, NACGT1, NAGCT12.4.1.1508.8 Prostaglandin and leukotriene metabolism PATH: hsa00590239ALOX12, LOG121.13.11.31246ALOX151.13.11.33240ALOX51.13.11.344056LTC4S2.5.1.374048LTA4H3.3.2.64051CYP4F3, CYP4F, LTB4H1.14.13.308529CYP4F21.14.13.305742PTGS1, PGHS-11.14.99.15743PTGS2, COX-2, COX21.14.99.127306PGDS5.3.99.25730PTGDS5.3.99.25740PTGIS, CYP8, PGIS5.3.99.46916TBXAS1, CYP55.3.99.5873CBR1, CBR1.1.1.1841.1.1.1891.1.1.197874CBR31.1.1.1849. Metabolism of Cofactors and Vitamins9.2 Riboflavin metabolism PATH: hsa0074052ACP13.1.3.48FMN -> RIBOFLAV + PI3.1.3.253ACP2FMN -> RIBOFLAV + PI3.1.3.254ACP5, TRAPFMN -> RIBOFLAV + PI3.1.3.255ACPP, PAPFMN -> RIBOFLAV + PI3.1.3.29.3 Vitamin B6 metabolism PATH: hsa007508566PDXK, PKH, PNKPYRDX + ATP -> P5P + ADP2.7.1.35PDLA + ATP -> PDLA5P + ADPPL + ATP -> PL5P + ADP9.4 Nicotinate and nicotinamide metabolism PATH: hsa0076023475QPRTQA + PRPP -> NAMN + CO2 + PPI2.4.2.194837NNMT2.1.1.1683BST1, CD157NAD -> NAM + ADPRIB3.2.2.5952CD38NAD -> NAM + ADPRIB3.2.2.523530NNT1.6.1.29.5 Pantothenate and CoA biosynthesis PATH: hsa007709.6 Biotin metabolism PATH: hsa007803141HLCS, HCS6.3.4.—6.3.4.96.3.4.106.3.4.116.3.4.15686BTD3.5.1.129.7 Folate biosynthesis PATH: hsa007902643GCH1, DYT5, GCH, GTPCH1GTP -> FOR + AHTD3.5.4.161719DHFRDHF + NADPH -> NADP + THF1.5.1.32356FPGSTHF + ATP + GLU <-> ADP + PI + THFG6.3.2.178836GGH, GH3.4.19.95805PTS4.6.1.106697SPR1.1.1.1535860QDPR, DHPR, PKU2NADPH + DHBP -> NADP + THBP1.6.99.79.8 One carbon pool by folate PATH: hsa0067010840FTHFD1.5.1.610588MTHFSATP + FTHF -> ADP + PI + MTHF6.3.3.29.10 Porphyrin and chlorophyll metabolism PATH: hsa00860210ALAD2 ALAV -> PBG4.2.1.243145HMBS, PBGD, UPS4 PBG -> HMB + 4 NH34.3.1.87390UROSHMB -> UPRG4.2.1.757389URODUPRG -> 4 CO2 + CPP4.1.1.371371CPO, CPXO2 + CPP -> 2 CO2 + PPHG1.3.3.35498PPOX, PPOO2 + PPHGm -> PPIXm1.3.3.42235FECH, FCEPPIXm -> PTHm4.99.1.13162HMOX1, HO-11.14.99.33163HMOX2, HO-21.14.99.3644BLVRA, BLVR1.3.1.24645BLVRB, FLR1.3.1.241.6.99.12232FDXR, ADXR1.18.1.23052HCCS, CCHL4.4.1.171356CP1.16.3.19.11 Ubiquinone biosynthesis PATH: hsa001304938OAS1, IFI-4, OIAS2.7.7.—4939OAS2, P692.7.7.—5557PRIM12.7.7.—5558PRIM2A, PRIM22.7.7.—5559PRIM2B, PRIM22.7.7.—7015TERT, EST2, TCS1, TP2, TRT2.7.7.—8638OASL, TRIP142.7.7.—10. Metabolism of Other Substances10.1 Terpenoid biosynthesis PATH: hsa0090010.2 Flavonoids, stilbene and lignin biosynthesis PATH: hsa0094010.3 Alkaloid biosynthesis I PATH: hsa0095010.4 Alkaloid biosynthesis II PATH: hsa0096010.6 Streptomycin biosynthesis PATH: hsa0052110.7 Erythromycin biosynthesis PATH: hsa0052210.8 Tetracycline biosynthesis PATH: hsa0025310.14 gamma-Hexachlorocyclohexane degradation PATH: hsa003615444PON1, ESA, PON3.1.8.13.1.1.25445PON23.1.1.23.1.8.110.18 1,2-Dichloroethane degradation PATH: hsa0063110.20 Tetrachloroethene degradation PATH: hsa006252052EPHX1, EPHX, MEH3.3.2.32053EPHX23.3.2.310.21 Styrene degradation PATH: hsa0064311. Transcription (condensed)11.1 RNA polymerase PATH: hsa0302011.2 Transcription factors PATH: hsa0302212. Translation (condensed)12.1 Ribosome PATH: hsa0301012.2 Translation factors PATH: hsa030121915EEF1A1, EF1A, ALPHA, EEF-1,3.6.1.48EEF1A1917EEF1A2, EF1A3.6.1.481938EEF2, EF2, EEF-23.6.1.4812.3 Aminoacyl-tRNA biosynthesis PATH: hsa0097013. Sorting and Degradation (condensed)13.1 Protein export PATH: hsa0306023478SPC183.4.21.8913.4 Proteasome PATH: hsa030505687PSMA6, IOTA, PROS273.4.99.465683PSMA2, HC3, MU, PMSA2, PSC23.4.99.465685PSMA4, HC93.4.99.465688PSMA7, XAPC73.4.99.465686PSMA5, ZETA, PSC53.4.99.465682PSMA1, HC2, NU, PROS303.4.99.465684PSMA3, HC83.4.99.465698PSMB9, LMP2, RING123.4.99.465695PSMB7, Z3.4.99.465691PSMB3, HC10-II3.4.99.465690PSMB2, HC7-I3.4.99.465693PSMB5, LMPX, MB13.4.99.465689PSMB1, HC5, PMSB13.4.99.465692PSMB4, HN3, PROS263.4.99.4614. Replication and Repair14.1 DNA polymerase PATH: hsa0303014.2 Replication Complex PATH: hsa0303223626SPO115.99.1.37153TOP2A, TOP25.99.1.37155TOP2B5.99.1.37156TOP3A, TOP35.99.1.28940TOP3B5.99.1.222. Enzyme Complex22.1 Electron Transport System, Complex I PATH: hsa0310022.2 Electron Transport System, Complex II PATH: hsa0315022.3 Electron Transport System, Complex III PATH: hsa0314022.4 Electron Transport System, Complex IV PATH: hsa0313022.5 ATP Synthase PATH: hsa0311022.8 ATPases PATH: hsa0323023. Unassigned23.1 Enzymes5538PPT1, CLN1, PPT, INCLC160ACP + H2O -> C160 + ACP3.1.2.2223.2 Non-enzymes22934RPIA, RPIRL5P <-> R5P5.3.1.65250SLC25A3, PHCPI + H <-> Hm + PIm6576CIT + MALm <-> CITm + MAL51166LOC51166AADP + AKG -> GLU + KADP2.6.1.395625PRODHPRO + FAD -> P5C + FADH21.5.3.—6517SLC2A4, GLUT4GLCxt -> GLC6513SLC2A1, GLUT1, GLUTGLCxt -> GLC26275HIBCH, HIBYL-COA-HHIBCOAm + H2Om -> HIBm + COAm3.1.2.423305KIAA0837, ACS2, LACS5, LACS2C160 + COA + ATP -> AMP + PPI + C160COA8611PPAP2A, PAP-2APA + H2O -> DAGLY + PI8612PPAP2C, PAP-2CPA + H2O -> DAGLY + PI8613PPAP2B, PAP-2BPA + H2O -> DAGLY + PI56994LOC56994CDPCHO + DAGLY -> PC + CMP10400PEMT, PEMT2SAM + PE -> SAH + PMME5833PCYT2, ETPETHM + CTP -> CDPETN + PPI10390CEPT1CDPETN + DAGLY <-> CMP + PE8394PIP5K1APINS4P + ATP -> D45PI + ADP8395PIP5K1B, STM7, MSS4PINS4P + ATP -> D45PI + ADP8396PIP5K2BPINS4P + ATP -> D45PI + ADP23396PIP5K1C, KIAA0589, PIP5K-GAMMAPINS4P + ATP -> D45PI + ADP24. Our own reactions which need to be found in KEGGGL3P <-> GL3PmT3P2 <-> T3P2mPYR <-> PYRm + HmADP + ATPm + PI + H -> Hm + ADPm + ATP + PImAKG + MALm <-> AKGm + MALASPm + GLU + H -> Hm + GLUm + ASPGDP + GTPm + PI + H -> Hm + GDPm + GTP + PImC160Axt + FABP -> C160FP + ALBxtC160FP -> C160 + FABPC180Axt + FABP -> C180FP + ALBxtC180FP -> C180 + FABPC161Axt + FABP -> C161FP + ALBxtC161FP -> C161 + FABPC181Axt + FABP -> C181FP + ALBxtC181FP -> C181 + FABPC182Axt + FABP -> C182FP + ALBxtC182FP -> C182 + FABPC204Axt + FABP -> C204FP + ALBxtC204FP -> C204 + FABPO2xt -> O2O2 <-> O2mACTACm + SUCCOAm -> SUCCm + AACCOAm3HB -> 3HBmMGCOAm + H2Om -> H3MCOAm4.2.1.18OMVAL -> OMVALmOIVAL -> OIVALmOICAP -> OICAPmC160CAR <-> C160CARmCAR <-> CARmDMMCOAm -> LMMCOAm5.1.99.1amino acid metabolismTHR -> NH3 + H2O + OBUT4.2.1.16THR + NAD -> CO2 + NADH + AMA1.1.1.103THR + NAD + COA -> NADH + ACCOA + GLYAASA + NAD -> NADH + AADP1.2.1.31FKYN + H2O -> FOR + KYN3.5.1.9CMUSA -> CO2 + AM6SA4.1.1.45AM6SA + NAD -> AMUCO + NADH1.2.1.32AMUCO + NADPH -> KADP + NADP + NH41.5.1.—CYSS + AKG <-> GLU + SPYRURO + H2O -> 4I5P4.2.1.494I5P + H2O -> FIGLU3.5.2.7GLU <-> GLUm + HmORN + Hm -> ORNmORN + Hm + CITRm <-> CITR + ORNmGLU + ATP + NADPH -> NADP + ADP + PI + GLUGSALGLYAm + ATPm -> ADPm + 2PGmAM6SA -> PICSPYR + H2O -> H2SO3 + PYRP5C <-> GLUGSALfatty acid synthesisMALCOA + ACP <-> MALACP + COA2.3.1.39ACCOA + ACP <-> ACACP + COAACACP + 4 MALACP + 8 NADPH -> 8 NADP + C100ACP + 4CO2 + 4 ACPACACP + 5 MALACP + 10 NADPH -> 10 NADP + C120ACP + 5CO2 + 5 ACPACACP + 6 MALACP + 12 NADPH -> 12 NADP + C140ACP + 6CO2 + 6 ACPACACP + 6 MALACP + 11 NADPH -> 11 NADP + C141ACP + 6CO2 + 6 ACPACACP + 7 MALACP + 14 NADPH -> 14 NADP + C160ACP + 7CO2 + 7 ACPACACP + 7 MALACP + 13 NADPH -> 13 NADP + C161ACP + 7CO2 + 7 ACPACACP + 8 MALACP + 16 NADPH -> 16 NADP + C180ACP + 8CO2 + 8 ACPACACP + 8 MALACP + 15 NADPH -> 15 NADP + C181ACP + 8CO2 + 8 ACPACACP + 8 MALACP + 14 NADPH -> 14 NADP + C182ACP + 8CO2 + 8 ACPC160COA + CAR -> C160CAR + COAC160CARm + COAm -> C160COAm + CARmfatty acid degredationGL3P + 0.017 C100ACP + 0.062 C120ACP + 0.1 C140ACP + 0.27C160ACP + 0.169 C161ACP + 0.055 C180ACP + 0.235C181ACP + 0.093 C182ACP -> AGL3P + ACPTAGLYm + 3 H2Om -> GLm + 3 C160mPhospholipid metabolismSAM + PMME -> SAH + PDMEPDME + SAM -> PC + SAHPE + SER <-> PS + ETHMMuscle contractionMYOACT + ATP -> MYOATP + ACTINMYOATP + ACTIN -> MYOADPACMYOADPAC -> ADP + PI + MYOACT + CONTRACT

[0155]

4

TABLE 2

// Homo Sapiens Core Metabolic Network //

// Glycolysis //

−1 GLC −1 ATP +1 G6P +1 ADP 0 HK1

−1 G6P −1 H2O +1 GLC +1 P1 0 G6PC

−1 G6P +1 F6P 0 GPIR

−1 F6P −1 ATP +1 FDP +1 ADP 0 PFKL

−1 FDP −1 H2O +1 F6P +1 PI 0 FBP1

−1 FDP +1 T3P2 +1 T3P1 0 ALDOAR

−1 T3P2 +1 T3P1 0 TPI1R

−1 T3P1 −1 PI −1 AND +1 NADH +1 13PDG 0 GAPDR

−1 13PDG −1 ADP +1 3PG +1 ATP 0 PGK1R

−1 13PDG +1 23PDG 0 PGAM1

−1 23PDG −1 H2O +1 3PG +1 PI 0 PGAM2

−1 3PG +1 2PG 0 PGAM3R

−1 2PG +1 PEP +1 H2O 0 ENO1R

−1 PEP −1 ADP +1 PYR +1 ATP 0 PKLR

−1 PYRm −1 COAm −1 NADm +1 NADHm +1

CO2m +1 ACCOAm 0 PDHA1

−1 AND −1 LAC +1 PYR +1 NADH 0 LDHAR

−1 G1P +1 G6P 0 PGM1R

// TCA //

−1 ACCOAm −1 OAm −1 H2Om +1 COAm +1 CITm 0 CS

−1 CIT +1 ICIT 0 ACO1R

−1 CITm +1 ICITm 0 ACO2R

−1 ICIT −1 NADP +1 NADPH +1 CO2 +1 AKG 0 IDH1

−1 ICITm −1 NADPm +1 NADPHm +1 CO2m +1 AKGm 0 IDH2

−1 ICITm −1 NADm +1 CO2m +1 NADHm +1 AKOm 0 IDH3A

−1 AKGm −1 NADm −1 COAm +1 CO2m +1

NADHm +1 SUCCOAm 0 OGDH

−1 GTPm −1 SUCCm −1 COAm +1

GDPm +1 PIm +1 SUCCAm 0 SUCLG1R

−1 ATPm −1 SUCCm −1 COAm +1

ADPm +1 PIm +1 SUCCOAm 0 SUCLA2R

−1 FUMm −1 H2Om +1 MALm 0 FHR

−1 MAL −1 AND +1 NADH +1 OA 0 MDH1R

−1 MALm −1 NADm +1 NADHm +1 OAm 0 MDH2R

−1 PYRm −1 ATPm −1 CO2m +1 ADPm +1 OAm +1 PIm 0 PC

−1 OA −1 GTP +1 PEP +1 GDP +1 CO2 0 PCK1

−1 OAm −1 GTPm +1 PEPm +1 GDPm +1 CO2m 0 PCK2

−1 ATP −1 CIT −1 COA −1 H2O +1

ADP +1 PT +1 ACCOA +1 OA 0 ACLY

// PPP //

−1 G6P −1 NADP +1 D6PGL +1 NADPH 0 G6PDR

−1 D6PGL −1 H2O +1 D6PGC 0 PGLS

−1 D6PGC −1 NADP +1 NADPH +1 CO2 +1 RL5P 0 PGD

−1 RL5P +1 X5P 0 RPER

−1 R5P −1 X5P +1 T3P1 +1 S7P 0 TKT1R

−1 X5P −1 E4P +1 F6P +1 T3P1 0 TKT2R

1 T3Pl −1 S7P +1 E4P +1 F6P 0 TALDO1R

−1 RL5P +1 R5P 0 RPIAR

// Glycogen //

−1 G1P −1 UTP +1 UDPG +1 PPI 0 UGP1

−1 UDPG +1 UDP +1 GLYCOGEN 0 GYS1

−1 GLYCOGEN −1 PI +1 G1P 0 GBE1

// ETS //

−1 MALm −1 NADPm +1 CO2m +1 NADPHm +1 PYRm 0 ME3

−1 MALm −1 NADm +1 CO2m +1 NADHm +1 PYRm 0 ME2

−1 MAL −1 NADP +1 CO2 +1 NADPH +1 PYR 0 ME1

−1 NADHm −1 Qm −4 Hm +1 QH2m +1 NADm +4 H 0 MTND1

−1 SUCCm −1 FADm +1 FUMm +1 FADH2m 0 SDHC1R

−1 FADH2m −1 Qm +1 FADm +1 QH2m 0 SDHC2R

−1 O2m −4 FEROm −4 Hm +4 FERIm +2 H2Om +4 H 0 UQCRFS1

−1 QH2m −2 FERIm −4 Hm +1 Qm +2 FEROm +4 H 0 COX5BL4

−1 ADPm −1 PIm −3 H +1 ATPm +3 Hm +1 H2Om 0 MTAT

−1 ADP −1 ATPm −1 PI −1 H +1

Hm +1 ADPm +1 ATP +1 PIm 0 ATPMC

−1 GDP −1 GTPm −1 PI −1 H +1

Hm +1 GDPm +1 GTP +1 PIm 0 GTPMC

−1 PPI +2 PI 0 PP

−1 ACCOA −l ATP −l C02 +1 MALCOA +1 ADP +1 PT 0 ACACAR

−1 GDP −1 ATP +1 GTP +1 ADP 0 GOT3R

// Transporters //

−1 CIT −1 MALm +1 CITm +1 MAL 0 CITMCR

−1 PYR −1 H +1 PYRm +1 Hm 0 PYRMCR

// Glycerol Phosphate Shuttle //

−1 GL3Pm −1 FADm +1 T3P2m +1 FADH2m 0 GPD2

−1 T3P2 −1 NADH +1 GL3P +1 AND 0 GPD1

−1 GL3P +1 GL3Pm 0 GL3PMCR

−1 T3P2 +1 T3P2m 0 T3P2MCR

// Malate/Aspartate Shuttle //

−1 OAm −1 GLUm +1 ASPm +1 AKGm 0 GOT1R

−1 ASP −1 AKG +1 OA +1 GLU 0 GOT2R

−1 AKG −1 MALm +1 AKGm +1 MAL 0 MALMCR

−1 ASPm −1 GLU −1 H +1 Hm +1 GLUm +1 ASP 0 ASPMC

// Exchange Fluxes //

+1 GLC 0 GLCexR

+1 PYR 0 PYRexR

+1 CO2 0 CO2exR

+1 O2 0 O2exR

+1 PI 0 PIexR

+1 H2O 0 H2OexR

+1 LAC 0 LACexR

+1 CO2m 0 CO2min

−1 CO2m 0 CO2mout

+1 O2m 0 O2min

−1 O2m 0 O2mout

+1 H2Om 0 H2Omin

−1 H2Om 0 H2Omout

+1 PIm 0 PImin

−1 PIm 0 PImout

// Output //

−1 ATP +1 ADP +1 P1 0 Output

0.0 end

end E 0

max

1 Output

0 end

0 GLCexR 1

−1000 PYRexR 0

−1000 LACexR 0

0 end 0

rev. rxn 33

nonrev. rxn 31

total rxn 64

matrix columns 97

unique enzymes 52

[0156]

5

TABLE 3

Abbrev.
Reaction
Rxn Name

Glycolysis

HK1
GLC + ATP -> G6P + ADP
HK1

G6PC, G6PT
G6P + H20 -> GLC + P1
G6PC

GPI
G6P <-> F6P
GPI

PFKL
F6P + ATP -> FDP + ADP
PFKL

FBP1, FBP
FDP + H2O -> F6P + PI
FBP1

ALDOA
FDP <-> T3P2 + T3P1
ALDOA

TPI1
T3P2 <-> T3P1
TPI1

GAPD, GAPDH
T3P1 + PI + NAD <-> NADH + 13PDG
GAPD

PGK1, PGKA
13PDG + ADP <-> 3PG + ATP
PGK1

PGAM1, PGAMA
13PDG <-> 23PDG
PGAM1

23PDG + H2O -> 3PG + P1
PGAM2

3PG <-> 2PG
PGAM3

ENO1, PPH, ENO1L1
2PG <-> PEP + H2O
ENO1

PKLR, PK1
PEP + ADP -> PYR + ATP
PKLR

PDHA1, PHE1A, PDHA
PYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm
PDHA1

LDHA, LDH1
NAD + LAC <-> PYR + NADH
LDHA

PGM1
G1P <-> G6P
PGM1

TCA

CS
ACCOAm + OAm + H2Om -> COAm + CITm
CS

ACO1, IREB1, IRP1
CIT <-> ICIT
ACO1

ACO2
CITm <-> ICITm
ACO2

IDH1
ICIT + NADP -> NADPH + CO2 + AKG
IDH1

IDH2
ICITm + NADPm -> NADPHm + CO2m + AKGm
IDH2

IDH3A
ICITm + NADm -> CO2m + NADHm + AKGm
IDH3A

OGDH
AKGm + NADm + COAm -> CO2m + NADHm + SUCCOAm
OGDH

SUCLG1, SUCLA1
GTPm + SUCCm + COAm <-> GDPm + PIm + SUCCOAm
SUCLG1

SUCLA2
ATPm + SUCCm + COAm <-> ADPm + PIm + SUCCOAm
SUCLA2

FH
FUMm + H2Om <-> MALm
FH

MDH1
MAL + NAD <-> NADH + OA
MDH1

MDH2
MALm + NADm <-> NADHm + OAm
MDH2

PC, PCB
PYRm + ATPm + CO2m -> ADPm + OAm + PIm
PC

ACLY, ATPCL, CLATP
ATP + CIT + COA + H2O -> ADP + PI + ACCOA + OA
ACLY

PCK1
OA + GTP -> PEP + GDP + CO2
PCK1

PPP

G6PD, G6PD1
G6P + NADP <-> D6PGL + NADPH
G6PD

PGLS, 6PGL
D6PGL + H2O -> D6PGC
PGLS

PGD
D6PGC + NADP -> NADPH + CO2 + RL5P
PGD

RPE
RL5P <-> X5P
RPE

TKT
R5P + X5P <-> T3P1 + S7P
TKT1

X5P + E4P <-> F6P + T3P1
TKT2

TALDO1
T3P1 + S7P <-> E4P + F6P
TALDO1

UGP1
G1P + UTP -> UDPG + PPI
UGP1

ACACA, ACAC, ACC
ACCOA + ATP + CO2 <-> MALCOA + ADP + PI + H
ACACA

ETS

ME3
MALm + NADPm -> CO2m + NADPHm + PYRm
ME3

MTND1
NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H
MTND1

SDHC
SUCCm + FADm <-> FUMm + FADH2m
SDHC1

FADH2m + Qm <-> FADm + QH2m
SDHC2

UQCRFS1, RIS1
O2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H
UQCRFS1

COX5BL4
QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H
COX5BL4

MTATP6
ADPm + PIm + 3 H -> ATPm + 3 Hm + H2Om
MTAT

PP, SID6-8061
PPI -> 2 PI
PP

Malate Aspartate shunttle

GOT1
OAm + GLUm <-> ASPm + AKGm
GOT1

GOT2
OA + GLU <-> ASP + AKG
GOT2

GDP + ATP <-> GTP + ADP
GOT3

Glycogen

GBE1
GLYCOGEN + PI -> G1P
GBE1

GYS1, GYS
UDPG -> UDP + GLYCOGEN
GYS1

Glycerol Phosphate Shunttle

GPD2
GL3Pm + FADm -> T3P2m + FADH2m
GPD2

GPD1
T3P2 + NADH -> GL3P + NAD
GPD1

RPIA, RPI
RL5P <-> R5P
RPIA

Mitochondria Transport

CIT + MALm <-> CITm + MAL
CITMC

GL3P <-> GL3Pm
GL3PMC

T3P2 <-> T3P2m
T3P2MC

PYR <-> PYRm + Hm
PYRMC

ADP + ATPm + PI + H -> Hm + ADPm + ATP + PIm
ATPMC

AKG + MALm <-> AKGm + MAL
MALMC

ASPm + GLU + H -> Hm + GLUm + ASP
ASPMC

GDP + GTPm + PI + H -> Hm + GDPm + GTP + PIm
GTPMC

[0157]

6

TABLE 4

Metabolic Reaction for Muscle Cells

Reaction
Rxt Name

GLC + ATP -> G6P + ADP
0 HK1

G6P <-> F6P
0 GPI

F6P + ATP -> FDP + ADP
0 PFKL1

FDP + H2O -> F6P + PI
0 FBP1

FDP <-> T3P2 + T3P1
0 ALDOA

T3P2 <-> T3P1
0 TPI1

T3P1 + PI + NAD <-> NADH + 13PDG
0 GAPD

13PDG + ADP <-> 3PG + ATP
0 PGK1

3PG <-> 2PG
0 PGAM3

2PG <-> PEP + H2O
0 ENO1

PEP + ADP -> PYR + ATP
0 PK1

PYRm + COAm + NADm -> + NADHm + CO2m + ACCOAm
0 PDHA1

NAD + LAC <-> PYR + NADH
0 LDHA

G1P <-> G6P
0 PGM1

ACCOAm + OAm + H2Om -> COAm + CITm
0 CS

CIT <-> ICIT
0 ACO1

CITm <-> ICITm
0 ACO2

ICIT + NADP -> NADPH + CO2 + AKG
0 IDH1

ICITm + NADPm -> NADPHm + CO2m + AKGm
0 IDH2

ICITm + NADm -> CO2m + NADHm + AKGm
0 IDH3A

AKGm + NADm + COAm -> CO2m + NADHm + SUCCOAm
0 OGDH

GTPm + SUCCm + COAm <-> GDPm + PIm + SUCCOAm
0 SUCLG1

ATPm + SUCCm + COAm <-> ADPm + PIm + SUCCOAm
0 SUCLA2

FUMm + H2Om <-> MALm
0 FH

MAL + NAD <-> NADH + OA
0 MDH1

MALm + NADm <-> NADHm + OAm
0 MDH2

PYRm + ATPm + CO2m -> ADPm + OAm + PIm
0 PC

ATP + CIT + COA + H2O -> ADP + PI + ACCOA + OA
0 ACLY

OA + GTP -> PEP + GDP + CO2
0 PCK1

OAm + GTPm -> PEPm + GDPm + CO2m
0 PCK2

G6P + NADP <-> D6PGL + NADPH
0 G6PD

D6PGL + H2O -> D6PGC
0 H6PD

D6PGC + NADP -> NADPH + CO2 + RL5P
0 PGD

RL5P <-> X5P
0 RPE

R5P + X5P <-> T3P1 + S7P
0 TKT1

X5P + E4P <-> F6P + T3P1
0 TKT2

T3P1 + S7P <-> E4P + F6P
0 TALDO1

RL5P <-> R5P
0 RPIA

G1P + UTP -> UDPG + PPI
0 UGP1

GLYCOGEN + PI -> G1P
0 GBE1

UDPG -> UDP + GLYCOGEN
0 GYS1

MALm + NADm -> CO2m + NADHm + PYRm
0 ME2

MALm + NADPm -> CO2m + NADPHm + PYRm
0 ME3

MAL + NADP -> CO2 + NADPH + PYR
0 HUMNDME

NADHm + Qm + 4 Hm -> QH2m + NADm + 4 H
0 MTND1

SUCCm + FADm <-> FUMm + FADH2m
0 SDHC1

FADH2m + Qm <-> FADm + QH2m
0 SDHC2

O2m + 4 FEROm + 4 Hm -> 4 FERIm + 2 H2Om + 4 H
0 UQCRFS1

QH2m + 2 FERIm + 4 Hm -> Qm + 2 FEROm + 4 H
0 COX5BL4

ADPm + PIm + 3 H -> ATPm + 3 Hm + H2Om
0 MTAT1

ADP + ATPm + PI + H -> Hm + ADPm + ATP + PIm
0 ATPMC

GDP + GTPm + PI + H -> Hm + GDPm + GTP + PIm
0 GTPMC

PPI -> 2 PI
0 PP

GDP + ATP <-> GTP + ADP
0 NME1

ACCOA + ATP + CO2 <-> MALCOA + ADP + PI + H
0 ACACA

MALCOA + ACP <-> MALACP + COA
0 FAS1_1

ACCOA + ACP <-> ACACP + COA
0 FAS1_2

ACACP + 4 MALACP + 8 NADPH -> 8 NADP + C100ACP + 4 CO2 + 4 ACP
0 C100SY

ACACP + 5 MALACP + 10 NADPH -> 10 NADP + C120ACP + 5 CO2 + 5
0 C120SY

ACP

ACACP + 6 MALACP + 12 NADPH -> 12 NADP + C120ACP + 6 CO2 + 6
0 C140SY

ACP

ACACP + 6 MALACP + 11 NADPH -> 11 NADP + C141ACP + 6 CO2 + 6
0 C141SY

ACP

ACACP + 7 MALACP + 14 NADPH -> 14 NADP + C160ACP + 7 CO2 + 7
0 C160SY

ACP

ACACP + 7 MALACP + 13 NADPH -> 13 NADP + C161ACP + 7 CO2 + 7
0 C161SY

ACP

ACACP + 8 MALACP + 16 NADPH -> 16 NADP + C180ACP + 8 CO2 + 8
0 C180SY

ACP

ACACP + 8 MALACP + 15 NADPH -> 15 NADP + C181ACP + 8 CO2 + 8
0 C181SY

ACP

ACACP + 8 MALACP + 14 NADPH -> 14 NADP + C182ACP + 8 CO2 + 8
0 C182SY

ACP

C160ACP + H2O -> C160 + ACP
0 PPT1

C160 + COA + ATP -> AMP + PPI + C160COA
0 KIAA

C160COA + CAR -> C160CAR + COA
0 C160CA

C160CARm + COAm -> C160COAm + CARm
0 C160CB

C160CARm + COAm + FADm + NADm -> FADH2m + NADHm +
0 HADHA

C140COAm + ACCOAm

C140COAm + 7 COAm + 7 FADm + 7 NADm -> 7 FADH2m + 7 NADHm + 7
0 HADH2

ACCOAm

TAGLYm + 3 H2Om -> GLm + 3 C160m
0 TAGRXN

GL3P + 0.017 C100ACP + 0.062 C120ACP + 0.1 C140ACP + 0.27
0 GAT1

C160ACP + 0.169 C161ACP + 0.055 C180ACP + 0.235 C181ACP + 0.093

C182CP -> AGL3P + ACP

AGL3P + 0.017 C100ACP + 0.062 C120ACP + 0.100 C140ACP + 0.270
0 AGPAT1

C160ACP + 0.169 C161ACP + 0.055 C180ACP + C181ACP + 0.093

C182ACP -> PA + ACP

ATP + CHO -> ADP + PCHO
0 CHKL1

PCHO + CTP -> CDPCHO + PPI
0 PCYT1A

CDPCHO + DAGLY -> PC + CMP
0 LOC

SAM + PE -> SAH + PMME
0 PEMT

SAM + PMME -> SAH + PDME
0 MFPS

PDME + SAM -> PC + SAH
0 PNMNM

G6P -> MI1P
0 ISYNA1

MI1P -> MYOI + PI
0 IMPA1

PA + CTP <-> CDPDG + PPI
0 CDS1

CDPDG + MYOI -> CMP + PINS
0 PIS

ATP + PINS -> ADP + PINSP
0 PIK3CA

ATP + PINS -> ADP + PINS4P
0 PIK4CA

PINS4P + ATP -> D45PI + ADP
0 PIP5K1

D45PI -> TPI + DAGLY
0 PLCB2

PA + H2O -> DAGLY + PI
0 PPAP2A

DAGLY + 0.017 C100ACP + 0.062 C120ACP + 0.100 C140ACP +
0 DGAT

0.270 C160ACP + 0.169 C161ACP + 0.055 C180ACP + 0.235 C181ACP +

0.093 C182ACP -> TAGLY + ACP

CDPDG + SER <-> CMP + PS
0 PTDS

CDPETN + DAGLY <-> CMP + PE
0 CEPT1

PE + SER <-> PS + ETHM
0 PESER

ATP + ETHM -> ADP + PETHM
0 EKI1

PETHM + CTP -> CDPETN + PPI
0 PCYT2

PS -> PE + CO2
0 PISD

3HBm + NADm -> NADHm + Hm + ACTACm
0 BDH

ACTACm + SUCCOAm -> SUCCm + AACOAm
0 3OCT

THF + SER <-> GLY + METTHF
0 SHMT1

THFm + SERm <-> GLYm + METTHFm
0 SHMT2

SERm + PYRm <-> ALAm + 3HPm
0 AGXT

3PG + NAD <-> NADH + PHP
0 PHGDH

PHP + GLU <-> AKG + 3PSER
0 PSA

3PSER + H2O -> PI + SER
0 PSPH

3HPm + NADHm -> NADm + GLYAm
0 GLYD

SER -> PYR + NH3 + H2O
0 SDS

GLYAm + ATPm -> ADPm + 2PGm
0 GLTK

PYR + GLU <-> AKG + ALA
0 GPT

GLUm + CO2m + 2 ATPm -> 2 ADPm + 2 PIm + CAPm
0 CPS1

AKGm + NADHm + NH3m <-> NADm + H2Om + GLUm
0 GLUD1

AKGm + NADPHm + NH3m <-> NADPm + H2Om + GLUm
0 GLUD2

GLUm + NH3m + ATPm -> GLNm + ADPm + PIm
0 GLUL

ASPm + ATPm + GLNm -> GLUm + ASNm + AMPm + PPIm
0 ASNS

ORN + AKG <-> GLUGSAL + GLU
0 OAT

GLU <-> GLUm + Hm
0 GLUMT

GLU + ATP + NADPH -> NADP + ADP + PI + GLUGSAL
0 P5CS

GLUP + NADH -> NAD + PI + GLUGSAL
0 PYCS

P5C <-> GLUGSAL
0 SPTC

HIS -> NH3 + URO
0 HAL

URO + H2O -> 4I5P
0 UROH

4I5P + H2O -> FIGLU
0 IMPR

FIGLU + THF -> NFTHF + GLU
0 FTCD

MET + ATP + H2O -> PPI + PI + SAM
0 MAT1A

SAM + DNA -> SAH + DNA5MC
0 DNMT1

SAH + H2O -> HCYS + ADN
0 AHCYL1

HCYS + MTHF -> THF + MET
0 MTR

SER + HCYS -> LLCT + H2O
0 CBS

LLCT + H2O -> CYS + HSER
0 CTH1

OBUT + NH3 <-> HSER
0 CTH2

CYS + O2 <-> CYSS
0 CDO1

CYSS + AKG <-> GLU + SPYR
0 CYSAT

SPYR + H2O -> H2SO3 + PYR
0 SPTB

LYS + NADPH + AKG -> NADP + H2O + SAC
0 LKR1

SAC + H2O + NAD -> GLU + NADH + AASA
0 LKR2

AASA + NAD -> NADH + AADP
0 2ASD

AADP + AKG -> GLU + KADP
0 LOC5

TRP + O2 -> FKYN
0 TDO2

FKYN + H2O -> FOR + KYN
0 KYNF

KYN + NADPH + O2 -> HKYN + NADP + H2O
0 KMO

HKYN + H2O -> HAN + ALA
0 KYNU2

HAN + O2 -> CMUSA
0 HAAO

CMUSA -> CO2 + AM6SA
0 ACSD

AM6SA -> PIC
0 SPTA

AM6SA + NAD -> AMUCO + NADH
0 AMSD

AMUCO + NADPH -> KADP + NADP + NH4
0 2AMR

ARG -> ORN + UREA
0 ARG2

ORN + Hm -> ORNm
0 ORNMT

ORN + Hm + CITRm <-> CITR + ORNm
0 ORNCITT

ORNm + CAPm -> CITRm + Pim + Hm
0 OTC

CITR + ASP + ATP <-> AMP <-> AMP + PPI + ARGSUCC
0 ASS

ARGSUCC -> FUM + ARG
0 ASL

PRO + FAD -> P5C + FADH2
0 PRODH

P5C + NADPH -> PRO + NADP
0 PYCR1

THR -> NH3 + H2O + OBUT
0 WTDH

THR + NAD -> CO2 + NADH + AMA
0 TDH

AMA + H2O + FAD -> NH3 + FADH2 + MTHGXL
0 MAOA

GLYm + THFm + NADm <-> METTHFm + NADHm + CO2m + NH3m
0 AMT

PHE + THBP + O2 -> TYR + DHBP + H2O
0 PAH

NADPH + DHBP -> NADP + THBP
0 QDPR

AKG + TYR -> HPHPYR + GLU
0 TAT

HPHPYR + O2 -> HGTS + CO2
0 HPD

HGTS + O2 -> MACA
0 HGD

MACA -> FACA
0 GSTZ1

FACA + H2O -> FUM + ACA
0 FAH

AKG + ILE -> OMVAL + GLU
0 BCAT1A

OMVALm + COAm + NADm -> MBCOAm + NADHm + CO2m
0 BCKDHAA

MBCOAm + FADm -> MCCOAm + FADH2m
0 ACADMA

MCCOAm + H2Om -> MHVCOAm
0 ECHS1B

MHVCOAm + NADm -> MAACOAm + NADHm
0 EHHADHA

MAACOAm -> ACCOAm + PROPCOAm
0 ACAA2

2 ACCOAm <-> COAm + AACCOAm
0 ACATm1

AKG + VAL -> OIVAL + GLU
0 BCAT1B

OIVALm + COAm + NADm -> IBCOAm + NADHm + CO2m
0 BCKDHAB

IBCOAm + FADm -> MACOAm + FADH2m
0 ACADSB

MACOAm + H2Om -> HIBCOAm
0 EHHADHC

HIBCOAm + H2Om -> HIBm + COAm
0 HIBCHA

HIBm + NADm -> MMAm + NADHm
0 EHHADHB

MMAm + COAm + NADm -> NADHm + CO2m + PROPCOAm
0 MMSDH

PROPCOAm + CO2m + ATPm -> ADPm + PIm + DMMCOAm
0 PCCA

DMMCOAm -> LMMCOAm
0 HIBCHF

LMMCOAm -> SUCCOAm
0 MUT

AKG + LEU -> OICAP + GLU
0 BCAT1C

OICAPm + COAm + NADm -> IVCOAm + NADHm + CO2m
0 BCKDHAC

OICAPm + COAm + NADH -> IVCOAm + NADHm + CO2m
0 BCKDHBC

OICAPm + COAm + NADHm -> IVCOAm + NADHm + CO2m
0 DBTC

IVCOAm + FADm -> MCRCOAm + FADH2m
0 IVD

MCRCOAm + ATPm + CO2m + H2Om -> MGCOAm + ADPm + Pim
0 MCCC1

MGCOAm + H2Om -> H3MCOAm
0 HIBCHB

H3MCOAm -> ACCOAm + ACTACm
0 HMGCL

MYOACT + ATP -> MYOATP + ACTIN
0 MYOSA

MYOATP + ACTIN -> MYOADPAC
0 MYOSB

MYOADPAC -> ADP + PI + MYOACT + CONTRACT
0 MYOSC

PCRE + ADP -> CRE + ATP
0 CREATA

AMP + H2O -> PI + ADN
0 CREATB

ATP + AMP <-> 2 ADP
0 CREATC

O2 <-> O2m
0 O2MT

3HB -> 3HBm
0 HBMT

CIT + MALm <-> CITm + MAL
0 CITMC

PYR <-> PYRm + Hm
0 PYRMC

C160CAR + COAm -> C160COAm + CAR
0 C160CM

OMVAL -> OMVALm
0 HIBCHC

OIVAL -> OIVALm
0 HIBCHD

OICAP -> OICAPm
0 HIBCHE

GL <-> GLm
0 GLMT

GL3Pm + FADm -> T3P2m + FADH2m
0 GPD2

T3P2 + NADH <-> GL3P + NAD
0 GPD1

GL3P <-> GL3Pm
0 GL3PMC

T3P2 <-> T3P2m
0 T3P2MC

OAm + GLUm <-> ASPm + AKGm
0 GOT1

OA + GLU <-> ASP + AKG
0 GOT2

AKG + MALm <-> AKGm + MAL
0 MALMC

ASPm + GLU + H -> Hm + GLUm + ASP
0 ASPMC

GLCxt -> GLC
0 GLUT4

O2xt -> O2
0 O2UP

C160Axt + FABP -> C160FP + ALBxt
0 FAT1

C160FP -> C160 + FABP
0 FAT2

C180Axt + FABP -> C180FP + ALBxt
0 FAT3

C180FP -> C180 + FABP
0 FAT4

C161Axt + FABP -> C161FP + ALBxt
0 FAT5

C161FP -> C161 + FABP
0 FAT6

C181Axt + FABP -> C181FP + ALBxt
0 FAT7

C181FP -> C181 + FABP
0 FAT8

C182Axt + FABP -> C182FP + ALBxt
0 FAT9

C182FP -> C182 + FABP
0 FAT10

C204Axt + FABP -> C204FP + ALBxt
0 FAT11

C204FP -> C204 + FABP
0 FAT12

PYRxt + HEXT <-> PYR + H
0 PYRUP

LACxt + HEXT <-> LAC + HEXT
0 LACUP

H <-> HEXT
0 HextUP

CO2 <-> CO2m
0 CO2MT

H2O <-> H2Om
0 H2OMT

ATP + AC + COA -> AMP + PPI + ACCOA
0 FLJ2

C160CAR <-> C160CARm
0 C160MT

CARm <-> CAR
0 CARMT

CO2xt <-> CO2
0 CO2UP

H2Oxt <-> H2O
0 H2OUP

Pixt + HEXT <-> HEXT + PI
0 PIUP

<-> GLCxt
0 GLCexR

<-> PYRxt
0 PYRexR

<-> CO2xt
0 CO2exR

<-> O2xt
0 O2exR

<-> PIxt
0 PIexR

<-> H2Oxt
0 H2OexR

<-> LACxt
0 LACexR

<-> C160Axt
0 C160AexR

<-> C161Axt
0 C161AexR

<-> C180Axt
0 C180AexR

<-> C181Axt
0 C181AexR

<-> C182Axt
0 C182AexR

<-> C20Axt
0 C204AexR

<-> ALBxt
0 ALBexR

<-> 3HB
0 HBexR

<-> GLYCOGEN
0 GLYex

<-> PCRE
0 PCREex

<-> TAGLYm
0 TAGmex

<-> ILE
0 ILEex

<-> VAL
0 VALex

<-> CRE
0 CREex

<-> ADN
0 ADNex

<-> PI
0 PIex

Human metabolic models and methods

Information

Publication Number

Date Filed

Date Published

Inventors

CPC

US Classifications

International Classifications

Abstract

Description

Claims

Parent Case Info

Provisional Applications (1)